ESPE Abstracts
Scientific Programme, ePosters & Abstracts
Menu
Search
Issues/Conferences
Cite
Contact
Disclaimer
Search
Issues/Conferences
Cite
Contact
Disclaimer
Previous issue
|
Volume 89
|
ESPE2018
|
Next issue
57th Annual ESPE (ESPE 2018)
Athens,
Greece
27 Sep 2018 - 29 Sep 2018
All volumes
0098 ESPE2024
0097 ESPE2023
0095 ESPE2022
0094 ESPE2021
0092 ESPE2019
0089 ESPE2018
0086 ESPE2016
0084 ESPE2015
0082 ESPE2014
ESPE 2018 57th European Society for Paediatric Endocrinology Annual Meeting 27-29 September 2018 Athens, Greece
Summary
Abstract Book
Programme
eposters
Abstracts
Contents
Plenary Lectures
Oncofertility: From Bench to Bedside to Babies
Oncofertility: From Bench to Bedside to Babies
hrp0089pl1
Oxytocin and the healing power of love
Oxytocin and the Healing Power of Love
hrp0089pl2
Clinical and molecular genetics of corticothroph pituitary tumours (Cushings Disease)
Abstract unavailable
hrp0089pl3
Prediction, Identification, and Treatment of Early Stage Type 1 Diabetes
Abstract unavailable
hrp0089pl4
Dynamic control of tissue glucocorticoids - lessons for optimising replacement therapy
Dynamic Control of Tissue Glucocorticoids - Lessons for Optimising Replacement Therapy
hrp0089pl5
Personalized treatments using gut microbiome and clinical data
Personalizing Treatments Using Microbiome and Clinical Data
hrp0089pl6
New curative treatment strategies for Type 1 Diabetes
Abstract unavailable
hrp0089pl7
Turner syndrome: new insights from prenatal genomics and transcriptomics
Turner Syndrome: New Insights from Prenatal Genomics and Transcriptomics
hrp0089pl8
Symposia
Recent developments in the understanding of Hypothalamo-pituitary disorders
Molecular Basis of Pituitary Hormone Deficiency: From Mouse to Man and Back
hrp0089s1.1
Stem Cells in the Pituitary: A Role for Regeneration?
hrp0089s1.2
A Novel Role for Vasopressin in Parenting
hrp0089s1.3
Gonads/DSD
The Biology of Germ Cell Tumors in Disorders of Sex Development
hrp0089s2.1
Disruption of Testicular Development and Function
hrp0089s2.2
Abstract unavailable
hrp0089s2.3
Recent consensus guidelines
Diagnosis and Management of Silver-Russell Syndrome: First International Consensus Statement
hrp0089s3.1
Abstract unavailable
hrp0089s3.2
Pediatric ObesityAssessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline
hrp0089s3.3
Prevention and Management of Rickets
hrp0089s3.4
Management of Late Effects of Cancer Therapy
Abstract unavailable
hrp0089s4.1
Hypogonadism in Girls after Cancer Therapy: Causes, Diagnosis, and Treatment
hrp0089s4.2
Diagnosis and Treatment of Hypogonadism in Male Survivors of Childhood Cancer
hrp0089s4.3
ISPAD - ESPE Preventing Late Complications in Children with T1D
Abstract unavailable
hrp0089s5.1
Re-defining Targets for Optimal T1D Control
hrp0089s5.2
Abstract unavailable
hrp0089s5.3
Molecular Mechanisms of Tissue Sensitivity to Glucocorticoids: Potential Clinical Implications
Cardiomyocyte Glucocorticoid and Mineralocorticoid Receptors Antagonistically Regulate Heart Disease
hrp0089s6.1
Immune Regulation by Glucocorticoids
hrp0089s6.2
Chemical Modification of the Glucocorticoid Receptor as a Determinant of Tissue Glucocorticoid Sensitivity: Implications to Circadian Rhythms, Stress Response and Treatment of Pediatric Leukemia
hrp0089s6.3
Bone
X-linked Hypophosphataemic Rickets: Disease and Treatment
hrp0089s7.1
Hypophosphatasia: Disease and Treatment
hrp0089s7.2
Achondroplasia - New Hopes
hrp0089s7.3
Thyroid disorders
Thyroid Hormone Transporter Defects
hrp0089s8.1
Central Hypothyroidism - an Update
hrp0089s8.2
Paediatric Differentiated Thyroid Cancer: Outcome and Long Term Effects
hrp0089s8.3
Novel advances in endocrine imaging
Abstract unavailable
hrp0089s9.1
Novel CNS Imaging Techniques
hrp0089s9.2
Novel Techniques in Diagnostics of Bone Strength
hrp0089s9.3
Paediatric obesity: Mechanisms and novel treatment
Abstract unavailable
hrp0089s10.1
Functional Leptin Deficiency Disorders and Treatment
hrp0089s10.2
MC4R Agonists in the Treatment of Monogenic Disorders of Obesity
hrp0089s10.3
Special Symposia: Nutrition and Growth
It is not Just the Growth Hormone-IGF-I Axis
hrp0089ss1.1
Fascinating Growth Phenomena: What Causes Individual Catch-up Growth and Population Secular Change?
hrp0089ss1.2
Interaction between Nutrition, the Endocrine System and the Growth Plate
hrp0089ss1.3
Meet the Expert
The Role of Radiology in the Diagnosis of Skeletal Dysplasias
The Role of Radiology in the Diagnosis of Skeletal Dysplasias
hrp0089mte1.1
Endocrine Complications in Thalassaemia
Endocrine Complications in Thalassaemia
hrp0089mte2.1
(1) (1)
Abstract unavailable
hrp0089mte3.1
The Use of Modern Technologies to Optimize Diabetes Care
The Use of Modern Technologies to Optimize Diabetes Care
hrp0089mte4.1
Gonadal function in congenital adrenal hyperplasia (CAH)
Gonadal Function in Congenital Adrenal Hyperplasia (CAH)
hrp0089mte5.1
Management of Hypo and Hypercalcaemia
Management of Hypo and Hypercalcaemia
hrp0089mte6.1
(1)
Abstract unavailable
hrp0089mte7.1
Psychology of childhood diabetes: How to motivate children and families with T1DM
Psychology of Childhood Diabetes: How to Motivate Children and Families with T1DM
hrp0089mte8.1
Novel Advances & Controversies in Paediatric Endocrinology
The clinical relevance of metabolomics; genomic engineering - CRISP-R/Cas9 and its many implications
The Clinical Relevance of Metabolomics
hrp0089na1.1
Abstract unavailable
hrp0089na1.2
Cell engineering for treatment of diabetes
Stem Cells as a Source of Beta Cells
hrp0089na2.1
Induction of Pancreatic Beta-Cell Neogenesis
hrp0089na2.2
Should growth hormone be used in ISS?
PRO: Should GH Be Used in ISS?
hrp0089con1.1
Abstract unavailable
hrp0089con1.2
Abstract unavailable
hrp0089con1.3
Abstract unavailable
hrp0089con1.4
To prime or not to prime?
PRO - To Prime or Not to Prime?
hrp0089con2.1
Con-To Prime or Not to Prime
hrp0089con2.2
Henning Anderson Award
EAP1 mutations cause an impaired transcriptional activity on GnRH promoter that leads to self-limited delayed puberty
EAP1 Mutations Cause an Impaired Transcriptional Activity on GnRH Promoter that Leads to Self-Limited Delayed Puberty
hrp0089ha1
Generating a human gonadal cells model from terminal differentiated fibroblast-derived induced pluripotent stem cells
Generating a Human Gonadal Cells Model from Terminal Differentiated Fibroblast-Derived Induced Pluripotent Stem Cells
hrp0089ha2
Working Groups
ESPE Disorders of Sex Development & Turner Syndrome Joint Session
Long-Term Outcomes in Males with 45,X/46,XY Mosaicism: A Multicenter Study of 59 Males
hrp0089wg1.1
Abstract unavailable
hrp0089wg1.2
Cardiovascular Pathology in Males and Females with 45,X/46,XY Mosaicism
hrp0089wg1.3
Abstract unavailable
hrp0089wg1.4
Abstract unavailable
hrp0089wg1.5
Abstract unavailable
hrp0089wg1.6
ESPE Obesity Working Group (OWG)
Abstract unavailable
hrp0089wg2.1
Abstract unavailable
hrp0089wg2.2
Abstract unavailable
hrp0089wg2.3
Abstract unavailable
hrp0089wg2.4
ESPE Bone and Growth Plate Working Group (BGP)
Abstract unavailable
hrp0089wg3.1
SHOX - From Gene to Growth Plate
hrp0089wg3.2
Abstract unavailable
hrp0089wg3.3
Abstract unavailable
hrp0089wg3.4
Abstract unavailable
hrp0089wg3.5
Abstract unavailable
hrp0089wg3.6
ESPE Diabetes Technology and Therapeutics Working Group
Abstract unavailable
hrp0089wg4.1
Abstract unavailable
hrp0089wg4.2
Use of Apps for Physical Activity in Type 1 Diabetes
hrp0089wg4.3
The Future Role of Machine Learning and Computer Vision in Carbohydrate Estimation for Patients with Diabetes
hrp0089wg4.4
Analyzing and Reporting of Sensor Glucose Levels
hrp0089wg4.5
Updates on the Developments of Decision Support Systems for the Treatment of Diabetes
hrp0089wg4.6
Use of Social Media for Improving Glucose Control in Patients with Type 1 Diabetes Use of Social Media for Improving Glucose Control in Patients with Type 1 Diabetes
hrp0089wg4.7
ESPE Paediatric and Adolescent Gynaecology Working Group (PAG)
Abstract unavailable
hrp0089wg5.1
Abstract unavailable
hrp0089wg5.2
Influence of Adiposity as a Determinant of the Age at Pubjeanertal Onset
hrp0089wg5.3
Endocrine-Metabolic Outcome of Women with a History of Sexual Precocity
hrp0089wg5.4
Abstract unavailable
hrp0089wg5.5
ESPE Gender Dysphoria (GD)
Abstract unavailable
hrp0089wg6.1
Abstract unavailable
hrp0089wg6.2
ESPE Paediatric Endocrine Nurse Specialists and Allied Health Professionals Working Group (PENS)
Advanced Anthropometrics in Pediatric Endocrinology: Utility and Difficulty
hrp0089wg7.1
Next Generation Nursing: Genomic Competencies for Pediatric Endocrine Nurses
hrp0089wg7.2
Abstract unavailable
hrp0089wg7.3
Abstract unavailable
hrp0089wg7.4
Abstract unavailable
hrp0089wg7.5
Free Communications
Adrenals & HPA Axis
A Novel Non-invasive Short Synacthen Test Validated in a Healthy Paediatric Population
hrp0089fc1.1
Long-term Effects of Prenatal Dexamethasone Treatment and Postnatal Glucocorticoid Treatment on Brain Structure in the Context of CAH
hrp0089fc1.2
Targetting the Binding of ACTH to the Melanocortin Receptor by Structure Modeling and Design of Peptide antagonists to Block Excess Androgens in 21-hydroxylase Deficiency
hrp0089fc1.3
Whole Exome Sequencing in Patients with Primary Generalized Glucocorticoid Resistance Identifies a Novel TRIM28 Gene Mutation (p.R230X)
hrp0089fc1.4
Untargeted Plasma Metabolomics in Subjects with Differences in Tissue Glucocorticoid Sensitivity Identifies a Novel metabolic Signature
hrp0089fc1.5
A Novel Stem Cell Model for the Triple A Syndrome
hrp0089fc1.6
Bone, Growth Plate & Mineral Metabolism 1
Burosumab, a Fully Human anti-FGF23 Monoclonal Antibody, for X-linked Hypophosphatemia (XLH): Sustained Improvement in two Phase 2 Trials in Affected Children 1-12 years old
hrp0089fc2.1
Whole Genome Sequencing Reveals Novel Intragenic Deletions of GNAS as Causes of Pseudohypoparathyroidism Type 1a
hrp0089fc2.2
Clinical Course of Hypoparathyroidism in Patients with APECED (APS1)
hrp0089fc2.3
Diagnostic Performance of Artificial Neural Network-based TW3 Skeletal Maturity Assessment
hrp0089fc2.4
Radial ESWT Stimulates Longitudinal Bone Growth in Cultured Rat Fetal Metatarsal Bones
hrp0089fc2.5
Final Height is Negatively Related to Disease Burden in Mitochondrial Disease
hrp0089fc2.6
Diabetes and Insulin 1
Neonatal Diabetes Owned to Potassium Channel Mutation: Response to Sulfonylureas According to the Genotype
hrp0089fc3.1
Genome-Wide Meta-Analysis Identifies a Novel Low Frequency STK39 Variant of Large Effect on Risk of Type 1 Diabetes
hrp0089fc3.2
Pediatric Patients with Type 1 Diabetes and Abnormal Nerve Conduction Studies Demonstrate Higher Neopterin Levels: Potential Role as a Biochemical Marker for Peripheral Neuropathy
hrp0089fc3.3
Is the Glycaemic Response from Fat in Meals Dose Dependent in Children and Adolescents with T1DM on Intensive Insulin Therapy?
hrp0089fc3.4
Genotype and Phenotype Correlation in Syndromic Forms of Hyperinsulinaemic Hypoglycaemia - a 10-year follow-up Study in a Tertiary Centre
hrp0089fc3.5
Using CRISPR/Cas9 Gene Editing to Study the Molecular Genetics of Congenital Hyperinsulinism
hrp0089fc3.6
GH & IGFs
Monogenic and Digenic Gene Mutations are Present in Children with Idiopathic Short Stature (ISS)
hrp0089fc4.1
Effects of IGF-1R Nuclear Localization in Glioblastoma Cells
hrp0089fc4.2
The Reduction in Longitudinal Growth Induced By PAPP-A2 Deficiency is Associated with Reduced Body Weight, Increased Energy Expenditure and Behavior Modification
hrp0089fc4.3
A Cross-Sectional Study of IGF-I Bioavailability Through Childhood and Associations with PAPP-A2, STC2 and Anthropometric Data
hrp0089fc4.4
Prediction of Adult Height by Artificial Intelligence (AI) through Machine Learning (ML) from Early Height Data
hrp0089fc4.5
Absorption and Excretion of Somapacitan, a Long-Acting Growth Hormone (GH) Derivative
hrp0089fc4.6
Thyroid
Beta1-Tubulin Gene (TUBB1) Mutations Cause Thyroid Dysgenesis Associated to Abnormal Platelet Morphology and Hyper-Aggregation
hrp0089fc5.1
Enrichment of Inherited Rare Variants in Non-Syndromic Congenital Hypothyroidism from Thyroid Dysgenesis Identified By Exome Sequencing: the Contribution of IKBKE to Vasculogenesis and Thyroid Development
hrp0089fc5.2
Computational Analysis of the Ligand Binding Domain of the Thyroid Hormone Receptor for the Rational Design of an Efficient Protein-Based Biosensor for the Detection of Thyroid Hormone Disrupting Chemicals
hrp0089fc5.3
Thyroid Hormone Analog Therapy in Patients with MCT8 deficiency: the Triac Trial
hrp0089fc5.4
Guidelines for the Management of Paediatric Differentiated Thyroid Carcinoma; a UK Endeavour
hrp0089fc5.5
Alterations in DNA Methylation Status of Gene Promoters in Children and Adolescents with Autoimmune Thyroid Disease
hrp0089fc5.6
Fat, Metabolism and obesity
Correlations Between Measures of Adiposity Across Childhood and Adolescence and the Intestinal Microbiota in 15-17 year-old Children with a Family History of Obesity: Preliminary Findings from the QUALITY Cohort
hrp0089fc6.1
Impaired Brain Satiety Responses to a Meal in Children with Obesity
hrp0089fc6.2
Role of PTEN in the Proliferation and Differentiation of Preadipocytes
hrp0089fc6.3
Identification of the First Obesity-Associated Mutations in Human Mesoderm-Specific Transcript (MEST) Result in Protein Overexpression, Adipocyte Hypertrophy and a Reduction in Adipocyte Mitochondrial Area
hrp0089fc6.4
The Role of Adipocytes in Childhood Precursor Bcell Lymphoblastic Leukemia
hrp0089fc6.5
MicroRNA-141 Directly Targets and Inhibits Sirtuins 1 Gene Expression and Its Elevation in Obese Subjects is Responsible for Reduced Levels of Sirtuin 1 and the Subsequent Hepatic Steatosis and Insulin Resistance
hrp0089fc6.6
Fetal, Neonatal Endocrinology and Metabolism
Expression and Localisation of Insulin, Glucagon, Amylin, Pancreatic Polypeptide and PDX-1 in Pancreatic Tissue of Children with Congenital Hyperinsulinism
hrp0089fc7.1
Enteroinsular Hormone Responses During Fasting, Oral glucose Tolerance Test and Mixed Meal in Children with Hyperinsulinaemic Hypoglycaemia
hrp0089fc7.2
Diazoxide-Induced Pulmonary Hypertension: UK Multicentre Retrospective Study on the Risk Factors, Monitoring Approach and Management Recommendations
hrp0089fc7.3
Altered Substrate Specificities and Metabolite Production by Aromatase (CYP19A1) Due to the R192H Mutation
hrp0089fc7.4
Thyroid Hormone Levels in Cord Blood are Associated with Fetal and Neonatal Growth
hrp0089fc7.5
TSH-Resistance and Remaining Low-T4 in Former Low-Birthweight Infants - A Study in Monozygotic Twins with Intra-Twin Birth-Weight-Differences
hrp0089fc7.6
Sex differentiation, Gonads and Gynaecology or Sex Endocrinology
Estrogen Receptor 2 Variant as a Novel Cause for Dysgenetic Ovaries
hrp0089fc8.1
Partial Restoration of Biological Effects of Estrogen in a Female with Estrogen Receptor [alpha] Variant
hrp0089fc8.2
Exomic Sequencing Uncovers Novel Genetic Associations for Deciphering Developmental Disorders (DDD) Study Participants with Hypospadias, Cardiovascular and Neurodevelopmental Abnormalities
hrp0089fc8.3
STARD8, a Novel Candidate Gene for 46,XY Disorders of Sex Development
hrp0089fc8.4
DEAH-Box Helicase 37defects (DXH37) Deffects are a Novel Cause of 46,XY Gonadal Dysgenesis
hrp0089fc8.5
The Roles of Steroids in Gonadal Development and Maintenance - Insights from a Zebrafish Model of Androgen and Cortisol Deficiency
hrp0089fc8.6
Pituitary, neuroendocrinology and Puberty 1
Novel Variants in the POU1F1 Beta Isoform are Associated with Isolated Growth Hormone Deficiency and Combined Pituitary Hormone Deficiency
hrp0089fc9.1
Contribution of Functionally Assessed GHRHR Mutations to Idiopathic Isolated Growth Hormone Deficiency in a Cohort of 312 Unrelated Patients
hrp0089fc9.2
Mutations in MAGEL2 and L1CAM are Associated with Congenital Hypopituitarism and Arthrogryposis
hrp0089fc9.3
Neuroendocrine Morbidity after Paediatric Craniopharyngioma: a Longitudinal Single Centre Analysis of 93 Patients Over 30 Years
hrp0089fc9.4
National Multidisciplinary Decision-Making Guideline for Children and Young People (Idiopathic Thickened Pituitary Stalk and/or Idiopathic Central Diabetes Insipidus
hrp0089fc9.5
National UK Guidelines for Screening, Multi-Disciplinary Team Management and Long-Term Follow-Up of Children and Young People (CYP) with Multiple Endocrine Neoplasia Type 1 (MEN1)
hrp0089fc9.6
Late Breaking
Burosumab Improved Rickets, Phosphate Metabolism, and Clinical Outcomes Compared to Conventional Therapy in Children with X-Linked Hypophosphatemia (XLH) - A Randomized Controlled Phase 3 Study
hrp0089fc10.1
Efficacy and Safety of Once-Weekly Somapacitan in Childhood Growth Hormone Deficiency: Results of a Randomised Open-Label, Controlled Phase 2 Trial
hrp0089fc10.2
Identification of the MAPK/ERK Pathway as a Novel Therapeutic Target in Adamantinomatous Craniopharyngioma
hrp0089fc10.3
Hypothalamus Sparing Surgery Improves the Outcome of Patients with Severe Initial Hypothalamic Involvement of Childhood Craniopharyngioma: Results of the Prospective Multinational Trial KRANIOPHARYNGEOM 2007
hrp0089fc10.4
A 5-Year Single-Centre Experience on the Safety and Efficacy of Sirolimus Therapy used for the Treatment of Congenital Hyperinsulinaemic Hypoglycaemia
hrp0089fc10.5
Primary Ovarian Insufficiency Incidence Rate and ETIOLOGY AMONG ISRAELI ADOLESCENTS between the Years 2000-2016 - A Multi-Center Study
hrp0089fc10.6
Bone, Growth Plate & Mineral Metabolism 2
Successful Immune Tolerance Induction in the First Case of Neutralizing Antibody Mediated Loss of Efficacy of Asfotase Alfa Treatment in Hypophosphatasia
hrp0089fc11.1
Elevated Phosphate Levels Inhibit Skeletal Muscle Cell Differentiation In vitro
hrp0089fc11.2
Evidence for Effects of FGF2 Aptamer in an Achondroplasia Mice Model and an In Vitro Chondrocyte Differentiation System Using Patient-Derived iPS Cells
hrp0089fc11.3
Using Patient Derived Induced Pluripotent Stem Cells to Model Multiple Epiphyseal Dysplasia
hrp0089fc11.4
A Recurrent 6-bp Intronic Deletion in NESP55 with Reduced Penetrance in Pseudohypoparathyroidism Type 1b
hrp0089fc11.5
Management of Severe, Protracted Hypocalcaemia in Patients Undergoing Thymus Transplantation in a Tertiary Centre: A 10-Year Experience
hrp0089fc11.6
Diabetes and Insulin 2
Continuous Glucose Monitoring Profiles in Healthy Non-Diabetic Children and Adolescents: A Multicenter Prospective Study
hrp0089fc12.1
Apoptosis and Oxidative Stress Markers During the Oral Glucose Tolerance Test (OGTT)
hrp0089fc12.2
Impact of Insulin Sensitivity and [beta]-cell Function on the Development of Impaired Glucose Tolerance (IGT) in Obese European Children and Adolescents
hrp0089fc12.3
How Does Thiol/Disulphide Homeostasis Change in Children with Type 1 Diabetes Mellitus?
hrp0089fc12.4
Effect of Homocysteine-Lowering Therapy on Diabetic Nephropathy in children and adolescents with Type 1 Diabetes
hrp0089fc12.5
Persistent Beneficial Effects of Metformin in Children and Adolescents with Type 1 Diabetes: Adelaide Metformin Randomized Controlled Trial Follow Up
hrp0089fc12.6
Pituitary, Neuroendocrinology and Puberty 2
Molecular Screening of Genes Associated with Central Precocious Puberty
hrp0089fc13.1
Ablation of AgRP Neurons Decreases Survival in Activity-Based Anorexia Model
hrp0089fc13.2
Role of GnRH Neuronal Migration and Development in Self-Limited Delayed Puberty
hrp0089fc13.3
The Kallman Syndrome Gene Product is Specifically Expressed in ACTH-Expressing Cells and Dysplays Sexual Dimorphism Expression in Human Fetal Pituitary
hrp0089fc13.4
Study of the Serum Kisspeptin Level in Healthy and Hypogonadotropic Boys
hrp0089fc13.5
Teamwork Saves Lives: How Pediatric Multidisciplinary care can Prevent 'Unexplained Deaths' in Adults with Prader-Willi Syndrome
hrp0089fc13.6
Multisystem Endocrine Disorders
Awareness and Participation in Rare Disease Registries Within the European Reference Network on Rare Endocrine Conditions (Endo-ERN)
hrp0089fc14.1
National UK Guidelines for the Clinical Assessment, Diagnosis, Treatment and Follow-up of Children and Young People (CYP) Under 19 Years of Age with Phaeochromocytoma (PCC) and Paraganglioma (PGL) - On Behalf of the UK Paediatric Phaeochromocytoma and Paraganglioma Guideline Development Group (GDG)
hrp0089fc14.2
Regulation of Salt, Sugar and Sex Steroids in Humans by Genetic Variations in NADPH Cytochrome P450 Oxidoreductase (POR) Identified in 1000 Genome Samples
hrp0089fc14.3
Glucocorticoid Deficiency Causes Differentially Dysregulated Oxidative Stress Depending on the Steroidogenic Defects
hrp0089fc14.4
Pubertal Females Produce an Enhanced Interferon-Alpha, Anti-viral Response Compared to Males, Which is Associated with X Chromosome Number, and Not Sex Hormones
hrp0089fc14.5
Sex Differences in Autoimmune Disease: Testosterone is Associated with a Decrease in Expression of Key Anti-viral Genes During Puberty, Which may Decrease the Risk of Autoimmunity in Males
hrp0089fc14.6
Growth and Syndromes
The Diagnostic Yield of a Targeted Next Generation Sequencing Panel in Children with Short Stature of Undefined Aetiology
hrp0089fc15.1
Effects of Caloric Restriction During Gestation on the Methylome of Offspring's Adipose Tissue and Reversibility of Such Effects by Metformin in a Swine Model
hrp0089fc15.2
Methylation of the C19MC microRNA Locus in the Placenta: A Mechanism whereby Maternal Body Size Links to that of the Child
hrp0089fc15.3
The Metabolic Profile Associated with RASopathies
hrp0089fc15.4
Utility of BDNF and MMP-1 as Markers of Cardiometabolic Risk in Turner Syndrome Girls
hrp0089fc15.5
Vosoritide for Children with Achondroplasia:a 30 Month Update from an Ongoing Phase 2 Clinical Trial
hrp0089fc15.6
Rapid Free Communications
Adrenals & HPA Axis
The Relative Contributions of Genetic and Environmental Factors on Cortisol Metabolism at Pre-, Mid- and Post-Pubertal Ages
hrp0089rfc1.1
Changes in CYP19A1 and CYP3A4 Activities due to Population Genetic Variations in Human P450 Oxidoreductase
hrp0089rfc1.2
Sphingosine-1-Phosphate Lyase (SGPL1) Deficiency is Associated with Mitochondrial Dysfunction
hrp0089rfc1.3
Mass Spectrometry-Based Assessment of Childhood Androgen Excess in 487 Consecutive Patients Over 5 Years
hrp0089rfc1.4
Quantitative Urinary GC-MS Based Steroid Analysis for Treatment Monitoring of Adolescents and Young Adults with Autoimmune Primary Adrenal Insufficiency
hrp0089rfc1.5
A Laboratory Harmonization Strategy for Steroid Hormone Profiling by MoM-Transformed, Normalized Reference Ranges Independent of Age, Sex and Units
hrp0089rfc1.6
Bone, Growth Plate & Mineral Metabolism 1
High-Resolution MRI Imaging of Bone-Muscle-Fat in Glucocorticoid Treated Boys with Duchenne Muscular Dystrophy: Results from the ScOT-DMD Study
hrp0089rfc2.1
S-25OHD is Associated with Hand Grip Strength and Myopathy at Five Years in Girls: An Odense Child Cohort Study
hrp0089rfc2.2
Measured Free 25-Hydroxyvitamin D in Healthy Children and Relationship to Total 25-Hydroxyvitamin D, Calculated Free 25-Hydroxyvitamin D and Vitamin D Binding Protein
hrp0089rfc2.3
Novel Severe Skeletal Dysplasia with Under-Mineralisation Associated with Reduced In Utero Calcium Transport and TRPV6 Compound Heterozygous Variants
hrp0089rfc2.4
Identification of Characteristic Neurological Complications in Infants with Achondroplasia by Routine MRI Screening
hrp0089rfc2.5
The Novel R211Q POP1 Homozygous Mutation Causes Severe Short Stature But Uniquely Only Subtle Skeletal Dysplasia
hrp0089rfc2.6
Diabetes and Insulin 1
Diagnostics of Early Atherosclerosis Risk in Kids (DEAR-Kids): Retinal Vessel Analysis in Pediatric Type 1 Diabetes - Retinal Arteriolar Narrowing Caused By High HbA1c
hrp0089rfc3.1
Personalized and Predictive Medicine for Pediatric Diabetes Through a Genetic Test Using Next Generation Sequencing
hrp0089rfc3.2
Significant Prevalence of Severe Monogenic Immune Defects Among Children with Type 1 Diabetes and Low T1D-Genetic Risk Score
hrp0089rfc3.3
Functional Characterization of a Novel KLF11 Mutation Identified in a Family with Autoantibody-Negative Type 1 Diabetes
hrp0089rfc3.4
Recent Secular Change in Pre- and Postnatal Growth and Adiposity in Infants of Mothers with Gestational Diabetes
hrp0089rfc3.5
Treatment Adherence and Weight Loss are Key Predictors of HbA1c One Year after Diagnosis of Childhood Type 2 Diabetes in UK
hrp0089rfc3.6
GH & IGFs
Abstract unavailable
hrp0089rfc4.7
Data Mining and Computational Analysis of Human Growth Hormone Gene (GH1) Sequence in Normal Population to Identify Potential Variants with Disease-Causing Effects
hrp0089rfc4.2
A Deletion Encompassing Exon 2 of the ALS Gene: Analysis of a Patient with ALS Deficiency and His Family
hrp0089rfc4.3
A Longitudinal Study on miRNAs Circulating Levels in a Cohort of SGA and AGA Subjects, Evaluated During Childhood and Young Adulthood
hrp0089rfc4.4
12-Month Effects of Once-Weekly and Twice-Monthly Administration of Hybrid Fc-Fused Human Growth Hormone, GX-H9, Treatment in Pediatric with GHD Deficiency
hrp0089rfc4.5
Effect of 2 Years of Growth Hormone Treatment on Glucose Tolerance in Adults with Prader-Willi Syndrome
hrp0089rfc4.6
Thyroid
Serum Levels of the Soluble Receptor for Advanced Glycation End Products are Reduced in Children with Hashimoto's Thyroiditis
hrp0089rfc5.1
Analysis of Chosen Polymorphisms rs7138803 A/G - FAIM2, rs7093069 C/T - IL-2RA, rs5742909 C/T - CTLA-4 in Pathogenesis of Hashimoto's Thyroiditis in Children
hrp0089rfc5.2
Incidence and Treatment Outcome of Childhood Thyrotoxicosis
hrp0089rfc5.3
The Value of Cytological, Histological and US Examination to Determine of Management Children with Nodular Goiter
hrp0089rfc5.4
Evidence for a Founder Effect in Multiple Endocrine Neoplasia 2
hrp0089rfc5.5
DUOX2 Deficiency in Quebec: From Life-Threatening Compressive Goiter in Infancy to Lifelong Euthyroidism
hrp0089rfc5.6
Fat, Metabolism and Obesity
Abstract unavailable
hrp0089rfc6.7
IGF-I at Four Months Associates to Visceral and Subcutaneous Adipose Tissue at 7 Years of Age
hrp0089rfc6.2
Effect of the Melanocortin-4 Receptor Agonist, Setmelanotide, on Obesity and Hyperphagia in Individuals Affected by Bardet-Biedl Syndrome
hrp0089rfc6.3
Functionality and Phenotypic Characteristics of Mutations in the Human Leptin Receptor
hrp0089rfc6.4
High-Throughput Untargeted Plasma Metabolomics Unravels Gender Dimorphic Metabolic Trajectories in Naturally Conceived and ICSI Prepubertal Children
hrp0089rfc6.5
Effects of Cherry's Extract on Increased Osteclastogenesis in Obese Children
hrp0089rfc6.6
Fetal, Neonatal Endocrinology and Metabolism
Next Generation Sequencing Results in 142 Patients with Congenital Hyperinsulinism
hrp0089rfc7.1
Outcomes of a Quality Improvement Project Integrating Continuous Glucose Monitoring Systems into the Routine Management of Neonatal Hypoglycaemia
hrp0089rfc7.2
Central Venous Cathether-Associated Thrombosis in Children with Congenital Hyperinsulinism
hrp0089rfc7.3
Expression of MIR-576-5p in Umbilical Cord as a Novel Biomarker for the Identification of Catch-up Growth in Small-For-Gestational-Age Infants
hrp0089rfc7.4
Alteration of Renal Corticosteroid Signaling Pathways in Preterm Infants: Neonatal Adaptation and Developmental Programming of Hypertension
hrp0089rfc7.5
Assessment of Pituitary Stalk Anatomy by T2 DRIVE without Gadolinium in Pituitary Diseases
hrp0089rfc7.6
Sex Differentiation, Gonads and Gynaecology or Sex Endocrinology
Male Fertility Genes Located in Y-Chromosomal Regions Display Differential mRNA Profiles in Response to GnRH Treatment of Cryptorchidism-Dependent Infertility
hrp0089rfc8.1
High Mobility Group Box 1 (HMGB1) is Increased in Adolescents with Polycystic Ovarian Syndrome (PCOS) and Decreases after Treatment with Myo-Inositol in Combination with [alpha]-Lipoic Acid (MYO+ALA)
hrp0089rfc8.2
Pharmacological Treatment of Adolescent Polycystic Ovary Syndrome (PCOS) According to the 2018 International Evidence-Based Guideline for the Assessment and Management of PCOS
hrp0089rfc8.3
Establishing Age, Sex, and Method Related Reference Ranges for Anogenital Distance - a Marker of In Utero Androgen Action
hrp0089rfc8.4
Latest Progress in Tissue Engineered Urethral Regeneration: From Rabbit to Dog, a Step from Human Clinical Trial for Surgical Treatment of VSD (Variation of Sex Development)
hrp0089rfc8.5
Metabolic Profile of Young Adult Transgender Persons Who Started Gender Affirming Treatment in their Adolescence
hrp0089rfc8.6
Pituitary, Neuroendocrinology and Puberty 1
Clinical and Genetic Features of Central Precocious Puberty Associated with Complex Phenotypes
hrp0089rfc9.1
Novel Variant in GNRHR Gene Regulatory Region in a Pedigree with Maternally Inherited Precocious Puberty
hrp0089rfc9.2
What is the Best Parameter to Decide the Initial Dose of Depot Leuprolide Acetate in Girls with Idiopathic Central Precocious Puberty?
hrp0089rfc9.3
REplacement of MAle mini-Puberty in Neonates and Children with Micropenis and Cryptorchidism due to Hypogonadotropic Hypogonadism: Results of the 'REMAP' Study ISRCTN13007297
hrp0089rfc9.4
Non-Isolated Central Precocious Puberty: Prevalence of Brain Lesions and Other Associated Disorders
hrp0089rfc9.5
Can Neuroimaging Predict Endocrine Morbidity in Congenital Hypothalamo-Pituitary (H-P) Disorders?
hrp0089rfc9.6
Late Breaking
Patients with GH Insensitivity and IGF-1 Resistance Harbour Copy Number Variants Causing a Silver-Russell-Like Phenotype
hrp0089rfc10.1
Non-Inferiority Clinical Trial on Gonadotropinversus Pulsatile Gonadotropin-Releasing Hormone Infusion Therapy in Male Adolescent Patient Withcongenital Hypogonadotropic Hypogonadism
hrp0089rfc10.2
Developmental Regulation of Obestatin and Adropin in Prader-Willi Syndrome and Non-Syndromic Obesity: Associations with Weight, BMI-z, HOMA-IR, and Lipid Profile
hrp0089rfc10.3
Comparative Analysis between Immunoassay and Tandem Mass Spectrometry for Androgens before and after Human Recombinant Gonadotrophin in Children with Genital Ambiguity and 46,XY Karyotype
hrp0089rfc10.4
Abstract unavailable
hrp0089rfc10.5
Effect of the Current Treatment of X-Linked Hypophosphatemia During Growth on the Development of Osteoarticular Lesions in the Hyp Mouse Model
hrp0089rfc10.6
Bone, Growth Plate & Mineral Metabolism 2
Diagnosis and Management of Pseudohypoparathyroidism and Related Disorders: First International Consensus Statement
hrp0089rfc11.1
Nationwide Hypophosphatemic Rickets Study
hrp0089rfc11.2
Increased Levels of Bone Formation and Resorption Markers in Patients with Hypophosphatemic Rickets
hrp0089rfc11.3
A New Form of Anhidrotic Ectodermal Dysplasia with Immunodeficiency Caused By Abolished Store-Operated Ca2+ Entry
hrp0089rfc11.4
The Determinants of Skeletal Fragility in Children with Type 1 Diabetes Mellitus
hrp0089rfc11.5
Reference Values of Automated Bone Age and Bone Health Index for Mexican Children and Adolescents
hrp0089rfc11.6
Diabetes and Insulin 2
Use of Acid-Suppressivemedications During Infancy and Early Childhood and Its Association with Type 1 Diabetes
hrp0089rfc12.1
Bone Mineral Density is Increased in 276 Danish Children and Adolescents with Type-1-Diabetes
hrp0089rfc12.2
Barriers and Sources of Support for the Performance of Physical Activity in Pediatric Type 1 Diabetes
hrp0089rfc12.3
Use of Telemonitoring Via a Mobile Device App Reduces HbA1c in Type 1 Diabetic Children and Adolescents
hrp0089rfc12.4
Insulin Gene Promoter Methylation Status in Greek Children and Adolescents with Type 1 Diabetes
hrp0089rfc12.5
AMGLIDIA, a Suspension of Glibenclamide for Patients with Neonatal Diabetes, Long Term Data on Efficiency and Tolerance
hrp0089rfc12.6
Pituitary, Neuroendocrinology and Puberty 2
Risk of Long-Term Endocrine Sequelae in Survivors of Progressing Childhood Optic Pathway Glioma (OPG) Treated by Upfront Chemotherapy: Preliminary Analyses of 102 Subjects from the French Multicentric BB-SFOP Registry
hrp0089rfc13.1
Growth Outcomes and Near Adult Height of Children with Congenital GH Deficiency (GHD) due to Abnormal Pituitary Development: Data from a Prospective, Multinational Observational Study
hrp0089rfc13.2
Circulating MKRN3, Kisspeptin and IGF-1 Levels in Girls During the Clinical Onset of Puberty
hrp0089rfc13.3
Gain in Predicted Adult Height Using the Combination of an LHRH Analogue and an Aromatase Inhibitor in Early Maturing Girls with Compromised Growth for 2 yrs or Until the Age of 11 is Maintained and Further Improved by Aromatase Inhibitor Monotherapy: Results on Final Height of the 'GAIL' Study ISRCTN11469487
hrp0089rfc13.4
Pubertal Voice Break: Temporal Relation of Secondary Sexual Characteristics in Healthy Boys
hrp0089rfc13.5
Close Correlation between Salivary and Blood Steroids in Normal Boys: Salivary Testosterone Best Characterizes Male Puberty
hrp0089rfc13.6
Multisystem Endocrine Disorders
Psychometric and Psycho-social Profile of Children and Adolescent Survivors of Pediatric Cancer
hrp0089rfc14.1
British Society for Paediatric Endocrinology and Diabetes Peer Review of Specialised Paediatric Endocrinology Services in the UK - Evaluation of the Outcomes
hrp0089rfc14.2
Dysregulated Glucose Homeostasis in Congenital Central Hypoventilation Syndrome
hrp0089rfc14.3
A Novel Germline DICER1 Mutation in a Girl with Multinodular Goiter and Ovarian Sertoli-Leydig Cell Tumor
hrp0089rfc14.4
Natural Course of MEN Type 2B Syndrome; a Dutch Single-Center Cohort
hrp0089rfc14.5
Identification of Epithelial Sodium Channel (ENaC) in Endometrial Pipelle Biopsy Samples
hrp0089rfc14.6
Growth and syndromes
Diagnosis of Silver-Russell Syndrome in Patients with Chromosome 14q32.2 Imprinted Region Disruption: Phenotypic and Molecular Analysis
hrp0089rfc15.1
Molecular and Clinical Analyses of Two UPD(16)mat Patients Detected by Screening of 94 Silver-Russell Syndrome Patients without Known Etiology
hrp0089rfc15.2
Multiple Pituitary Hormone Deficiencies and Early Onset Obesity in Two Siblings with a Mutation in the MAGEL2-gene: Evidence for an Important Regulatory Function of the MAGEL2-gene in the Hypothalamic-Pituitary Hormone Pathways
hrp0089rfc15.3
Characteristics, Effectiveness and Safety Data from Clinically Relevant Subgroups of Patients with Severeprimary IGF-I Deficiency (SPIGFD): Results from the European Increlex® Growth Forum Database (EU-IGFD) Registry
hrp0089rfc15.4
Effect of Adjusting for Tanner Stage Age on Short and Tall Stature Prevalence in US Youths
hrp0089rfc15.5
Latest Results from PATRO Children, a Multi-Centre, Non-Interventional Study of the Long-Term Safety and Efficacy of Omnitrope® in Children Requiring Growth Hormone Treatment
hrp0089rfc15.6
Poster Presentations
Adrenals and HPA Axis P1
Evaluation of Long Term Metabolic Effects After Prenatal Dexamethasone Treatment in the Context of CAH - the Swedish Cohort
hrp0089p1-p001
Obesity and Cardio-metabolic Risk Factors among Children and Adolescents with Non-Classic 21-Hydroxylase Deficiency
hrp0089p1-p002
Cognition in Children with Congenital Adrenal Hyperplasia
hrp0089p1-p003
Carriers of CYP21A2 Mutations have Decreased Mortality in Infectious Diseases, Anational Population Registry Study
hrp0089p1-p004
Elevated Concentrations of Adrenal Steroid Precursors with Glucocorticoid Activity Might Prevent Addisonian Crisis in Untreated Patients with Classic Congenital Adrenal Hyperplasia
hrp0089p1-p005
Altered DNA Methylation in Peripheral T-cells from Patients with Congenital Adrenal Hyperplasia
hrp0089p1-p006
Birth Incidence, Age at Diagnosis, Mortality in Congenital Adrenal Hyperplasia in Korea: A Nationwide Population-based Study
hrp0089p1-p007
Impact of Puberty on Final Height in Children and Adolescents with Congenital Adrenal Hyperplasia (CAH)
hrp0089p1-p008
The Relationship of Baseline, Incremental and Peak Cortisol Following a Short Synacthen Test - Single-centre Analysis of Three Years' Data
hrp0089p1-p009
The Circadian Rhythm of Cortisol Binding Globulin has Little Impact on Cortisol Exposure after Hydrocortisone Dosing
hrp0089p1-p010
Characterizing the Steroidome in Ammniotic Fluid of Mid-gestation by LC-MS/MS
hrp0089p1-p011
Pediatric Adrenocortical Tumors. A Single Tertiary Center Experience: Clinical, Biological and Pathologic Characteristics Analysis
hrp0089p1-p012
Role of Mast Cells in the Establishment of the Mineralocorticoid Pathway in the Developing Mouse
hrp0089p1-p013
Molecular Characterization of TNXA/TNXB Chimeras in CYP21A2 Gene Deletions: High Frequency of Undiagnosed Ehlers-Danlos Syndrome in Congenital Adrenal Hyperplasia Patients
hrp0089p1-p014
New Insights into Low Dose Dexamethasone Suppression Test in Paediatric Cushing's Syndrome
hrp0089p1-p015
Recurrent Hypoglycemia in a Preschooler Girl with Overgrowth: Isolated ACTH-Deficiency with a Novel TPIT Mutation
hrp0089p1-p016
Biochemical, Genetic and Molecular Characterization of a Novel P399_E401Dup Mutation in P450 Oxidoreductase (POR) Altering Several Enzymatic Activities in a Patient with a 46,XX DSD Phenotype at Birth
hrp0089p1-p017
Young Lean Women with Evidence of Both Premature Adrenarche and Pubarche Display a Metabolic, Hormonal and Psychologic Profile that is Similar to that of their Peers with Polycystic Ovary Syndrome
hrp0089p1-p018
The Usefulness of Combined Analysis of Serum and Salivary Maximum Cortisol Response to Low-Dose ACTH Test to Define the Requirement of Hormone Replacement Treatment
hrp0089p1-p019
High DHEAS (HD) in Girls Determines Earlier Pubertal Maturation and Mild Hyperandrogenism throughout Pubertal Development
hrp0089p1-p020
Higher Dehydroepiandrosterone Levels in Prepubertal Children Born Very Preterm
hrp0089p1-p021
A Large Consanguineous Family with a Mild and Transient form of Autosomal Recessive Pseudohypoaldosteronism type 1 (PHA1) Caused by a Novel Mutation in the SCNN1A Gene: Functional Studies
hrp0089p1-p022
Associations Between Maternal and Offspring Hair Cortisol Concentrations and Child Behavioral Symptoms in Pairs of Children 18-48 Months Old and their Mothers With and Without Perinatal Mental Disorders
hrp0089p1-p023
Gonadotropin-Dependent Pubertal Disorders are Common in Patients with Virilizing Adrenocortical Tumors in Childhood
hrp0089p1-p024
Adrenals and HPA Axis P2
Contribution of Direct Measurements of Steroids by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) in Non-classical Adrenal Hyperplasia (NCCAH)
hrp0089p2-p001
GnRH-analogue Treatment in Children with Congenital Adrenal Hyperplasia (CAH): Data from a Multicenter CAH Registry
hrp0089p2-p002
Glucocorticoid Replacement Regimens in the Treatment of 21-hydroxylase Deficiency Congenital Adrenal Hyperplasia: A Systematic Cochrane Review
hrp0089p2-p003
Hydrocortisone (HC) Dose in Children with Congenital Adrenal Hyperplasia (CAH)
hrp0089p2-p004
Perioperative Care of CAH - Incongruencies of Practices among Canadian Specialists
hrp0089p2-p005
Analysis of Phenotypes and Genotypes in 84 Patients with 21-hydroxylase Deficiency
hrp0089p2-p006
Miscarriages in Families with a Child with Classic Congenital Adrenal Hyperplasia and 21-Hydroxylase Deficiency (CAH)
hrp0089p2-p007
Testing Antiandrogens and Aromatase Inhibitors to Achieve Normal Growth in Children with Classical Congenital Adrenal Hyperplasia: A Systematic Review and Meta-analysis
hrp0089p2-p008
Phenotype-genotype Correlations of CYP21A2 Mutations in Patients with Congenital Adrenal Hyperplasia in Turkey
hrp0089p2-p009
Hypoglycemic Crisis and Salt Loss in Children with Classic Congenital Adrenal Hyperplasia
hrp0089p2-p010
Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38 935 Infants
hrp0089p2-p011
Autoantibodies Against 21-Hydroxylase in Prediction of Adrenal Failure in APECED Patients
hrp0089p2-p012
A First Combination Case of 21-Hydroxilase Deficiency and CHARGE Syndrome Confirmed by Genetic Analysis
hrp0089p2-p013
Frequency of Enzyme Deficiencies in a Turkish Cohort of Congenital Adrenal Hyperplasia: A Single-Center Experience with 145 Patients
hrp0089p2-p014
Study of Cardiovascular Risk Factors and Carotid Intima-Media Thickness in Children with Congenital Adrenal Hyperplasia
hrp0089p2-p015
The Spectrum of Genetic Defects in Congenital Adrenal Hyperplasia in the Population of Cyprus: A Retrospective Analysis
hrp0089p2-p016
Childhood Growth Advancement in Girls with Premature Adrenarche Heralds Anabolic Effects by Adulthood
hrp0089p2-p017
A Novel Mutation in the MC2R Gene in a Two-year-old Boy with Adrenal Insufficiency
hrp0089p2-p018
Two Cases of Apparent Mineralocorticoid Excess due to Novel Mutations in HSD11B2 Gene
hrp0089p2-p019
Long-term Follow-up of Safety and Disease Control for Hydrocortisone Granules Designed to give Age-appropriate Dosing with Taste Masking to Children with Adrenal Insufficiency
hrp0089p2-p020
Borderline Peak Plasma Cortisol Following Synacthen Stimulation - Single-centre Analysis of Three Years Data
hrp0089p2-p021
Unilateral Adrenalectomy for Primary Pigmented Nodular Adrenocortical Disease Causing Cushing Syndrome
hrp0089p2-p022
Adrenal Crisis in Children with Adrenal Insufficiency: Prevalence and Risk Factors
hrp0089p2-p023
The Effectiveness of a Stress-Management Intervention Program in Behavioral Parameters and Hair Cortisol Concentrations in Children with Attention Deficit Hyperactivity Disorder
hrp0089p2-p024
Very High Dehydroepiandrosterone Sulfate (DHEAS) in Serum of an Overweight Female Adolescent without a Tumor
hrp0089p2-p025
Early Recognition of Adrenal Insufficiency after Hematopoietic Stem Cell Transplantation During Childhood
hrp0089p2-p026
Reference Values for Serum 17-alfa Hydroxyprogesterone and Adrenal Size in Healthy Newborns
hrp0089p2-p027
A Rare Case of ACTH-Independent Cushing's Syndrome due to Bilateral Micronodular Adrenal Hyperplasia and Myoclonic Dystonia
hrp0089p2-p028
Two Siblins and Three Cousins with Allgrove (4A) Syndrome in a Turkısh Family: A Novel Mutation in the 'Aladin' Gene
hrp0089p2-p029
Ganglioneuroma Presenting as an Adrenal Incidentaloma in a 10-year-old boy-a Rare Entity
hrp0089p2-p030
The Relationship Between Vitamin D Status and Metabolic Abnormalities in Females with Classical Congenital Adrenal Hyperplasia: A Pilot Study
hrp0089p2-p031
Adrenal Hypoplasia Seemingly First as a Primary Hypoaldosteronism
hrp0089p2-p032
Quantitative Ultrasound Evaluation in a Cohort of 43 Young Adults with Classical CAH due to 21-Hydroxylase Deficiency (21OHD): Is Bone Mineral Quality Impaired?
hrp0089p2-p033
Etiology of Primary Adrenal Insufficiency in Children: a 29-year Single Center Experience
hrp0089p2-p034
Pseudopubertas Praecox in a 4 Year Old Boy with Bilateral Atypical Adrenocortical Adenomas
hrp0089p2-p035
Adrenals and HPA Axis P3
Congenital Adrenal Hyperplasia: A Patient's Perspective, a Mother's Story
hrp0089p3-p001
An Extremely Rare Cause of Cushing Syndrome in Chidhood
hrp0089p3-p002
Nelson's Syndrome after Bilateral Adrenalectomy for Cushing's Disease in Pediatric Age - Report of a Case
hrp0089p3-p003
Basal Levels of 17-hydroxyprogesterone can Distinguish Isolated Precocious Pubarche from Non-Classical Congenital Adrenal Hyperplasia in Children: A Prospective Observational study
hrp0089p3-p004
Age at Diagnosis and Outcome in Maghreb patients with 21-hydroxylase Deficient Congenital Adrenal Hyperplasia; Urgent need for Newborn Screening
hrp0089p3-p005
An Adrenal Tumor Ppresenting as a Premature Pubarche in a 7 Year-old Girl
hrp0089p3-p006
Refractory Cyclical Cushing's Disease - a Case of Multiple Pituitary Micro-adenomas in a Three Year Old Girl after 8 Years Follow up
hrp0089p3-p007
Topical Corticosteroid-Induced Adrenal Insufficiency
hrp0089p3-p008
Early Diagnosis of Duchenne Muscular Dystrophy in 6-Months-Old Male with Primary Adrenal Insufficiency
hrp0089p3-p009
Lipoid Adrenal Hyperplasia Diagnosed with Severe Cholestasis in Newborn
hrp0089p3-p010
Severe Hyponatraemia with Absence of Hyperkalaemia in a Patient with Addison's Disease
hrp0089p3-p011
Deep Bronze Skin without Sun Exposition in a 16-Year Old Girl
hrp0089p3-p012
Case of Primary Pigmented Nodular Adrenocortical
hrp0089p3-p013
Two Case Report of Adrenocortical Adenoma
hrp0089p3-p014
A Homozygous Mutation c.518T>A (p.lle173Asn) of the CYP21A2 Gene Presenting as Non-Classical Congenital Adrenal Hyperplasia (NCAH)
hrp0089p3-p015
Adrenals and HPA Axisa; Atypical Presentation of Adrenal Insufficiency
hrp0089p3-p016
Non-classic Congenital Adrenal Hyperplasia Causing Alleles among Adolescent Girls with PCOS - Genetical Study
hrp0089p3-p017
Adequate Interpretation of Cortisol Levels in Children
hrp0089p3-p018
Erythrocytosis as First Manifestation of Adrenal Mass
hrp0089p3-p019
A Neonatal Case with Familial Glucocorticoid Deficiency Type 1 Having Adrenal Crisis in Early Period
hrp0089p3-p020
Presenting Features, Clinical Characteristics and Follow up of Familial Isolated Glucocorticoid Deficiency (FGD) due to Mutations in MC2R and MRAP Genes
hrp0089p3-p021
Identification of X-linked Adrenoleukodystrophy in Boys Presenting with Adrenal Insufficiency in the Absence of Adrenal Antibodies
hrp0089p3-p022
Secondary Hyperaldosteronism in the Course of Cystic Fibrosis
hrp0089p3-p023
The P30L Mutation in the CYP21A2 Gene in a Girl with Congenital Adrenal Hyperplasia with Hidden Salt Loosing and Central Precocious Puberty
hrp0089p3-p024
Congenital Adrenal Hyperplasia due to a Rare Homozygous Mutation R483P in the CYP21A2 Gene and Coexisting Growth Hormone Deficiency
hrp0089p3-p025
Rare Case of Androgen Producing Tumor in 14 Month Old Girl
hrp0089p3-p026
Adrenocortical Tumours in Children - A Case Series
hrp0089p3-p027
Discrete Virilization in Girls with the Classic Form of Congenital Adrenal Hyperplasia: the Importance of a Detailed Genital Examination at Birth
hrp0089p3-p028
A New Methodology for Early Identification of Steroid Resistant Acute Graft-Versus-Host Disease Patients
hrp0089p3-p029
Delayed Diagnosis of a Patient with Antley-Bixler Syndrome
hrp0089p3-p030
Clinical and Biochemical Phenotype of Aldosterone Synthase Deficiency
hrp0089p3-p404
Is the Third Time Really a Charm? The Story about Three Brothers Suffering from Adrenoleukodystrophy and about HSCT being a Chance to Stop the Unstoppable Disease
hrp0089p3-p414
Bone, Growth Plate & Mineral Metabolism P1
Intrauterine Growth Restriction, Antenatal Steroids, Gestational Age and Breast Feeding Influence Bone Health in Prepubertal Children Born Preterm
hrp0089p1-p025
Duration of Breastfeeding and Bone Mineral Density in Childhood - A Prospective Study Among Preschool Children
hrp0089p1-p026
Bone Health in Adolescents Born Small for Gestational Age (SGA)
hrp0089p1-p027
Longitudinal Study of Bone Mass in Swedish Children Treated with Modified Ketogenic Diet
hrp0089p1-p028
Fracture Epidemiology for Children in Western Australia between 2005-2015: Do We Need to be Concerned about Bone Health?
hrp0089p1-p029
Bone Biochemistry in Children with Fractures Presenting with Suspected Non-accidental Injury
hrp0089p1-p030
Systematic Screening Using DXA Lateral Vertebral Morphometry is Associated with a High Prevalence of Vertebral Fractures in Duchenne Muscular Dystrophy: Results from ScOT-DMD Study
hrp0089p1-p031
Bone Mineral Density and Glycemic Control in Children and Adolescents with Type 1 Diabetes Mellitus
hrp0089p1-p032
Comparison of Manual and Automated Bone Age Assessment in 1285 Children and Adolescents Aged 5 to 16 Years
hrp0089p1-p033
Is Plasma C-Type Natriuretic Peptide Level Available for Typing and Diagnosis of Skeletal Dysplasia Cases?
hrp0089p1-p034
Long-term Outcomes of Osteogenesis Imperfecta in the Bisphosphonate Era
hrp0089p1-p035
Novel LRP5 Loss-of-function Mutation Causes Osteoporosis-pseudoglioma Syndrome
hrp0089p1-p036
Hypercalcaemia after Treatment with Denosumab in Children: Bisphosphonates as an Option for Therapy and/or Prevention?
hrp0089p1-p037
Disease Burden and Systemic Manifestations of HPP in Children Enrolled in the Global HPP Registry
hrp0089p1-p038
3-epi-25 Serum 25-hydroxyvitamin D3 Concentrations in Chilean Children between 5 and 8 Years
hrp0089p1-p039
Bone, Growth Plate & Mineral Metabolism P2
Length Estimation Based on Clinical and Anthropometric Measures in Newborns
hrp0089p2-p036
Vitamin D Deficient (Nutritional) Rickets Presenting in Infancy
hrp0089p2-p037
The Effect of Vitamin D Receptor Polymorphism on Bone Mineral Density in Egyptian Patients with Beta Thalassemia Major
hrp0089p2-p038
Vitamin D in Adolescents: A Comprehensive Review of Guidelines and Recommendations
hrp0089p2-p039
X-linked Hypophosphatemia Registry - An International Prospective Patient Registry
hrp0089p2-p040
Clinical and Biological Parameters Associated to the Severity of X-linked Hypophosphatemia in Children
hrp0089p2-p041
High Fibroblast Growth Factor (FGF) 23: An Unusual Cause of Severe Osteoporosis in a Patient with Chronic Liver Disease
hrp0089p2-p042
Metabolic Syndrome in Children with X-linked Hypophosphatemic Rickets (XLHR)
hrp0089p2-p043
High Incidence of Cranial Synostosis and Chiari Malformation in Children with X-linked Hypophosphatemic Rickets
hrp0089p2-p044
An Unusual Case of Hypophosphatemia in a Child Affected by Di George Syndrome
hrp0089p2-p045
Novel SLC34A1 Mutation in a Girl Infant with Idiopathic Infantile Hypercalcemia
hrp0089p2-p046
A Novel Variant of SLC34A1 Gene in an Infant with Idiopathic Infantile Hypercalcemia
hrp0089p2-p047
Infantile Arterial Calcification and Subsequent Hypophosphatemia due to ENPP1 Mutation - A Case Followed through to Adulthood
hrp0089p2-p048
Pediatric Quality of Life Inventory in Children with Osteogenesis Imperfect in Dr Soetomo Hospital Surabaya
hrp0089p2-p049
Osteoporosis-pseudoglioma Syndrome (OPPG): Improvement of Osteoporosis on Biphosphonate Therapy
hrp0089p2-p050
Bone Marrow Adiposity and IGF System in Obese Children and Adolescents
hrp0089p2-p051
Evaluation of Bone Mineral Density in a Cohort of Children with Growth Hormone Deficiency
hrp0089p2-p052
Follow-up on Bone Health in Children with Acute Lymphoblastic Leukemia (ALL)
hrp0089p2-p053
Effect of Pubertal Inductionn Bone Mass Accrual, in Adolescent Boys with Duchenne Muscular Dystrophy
hrp0089p2-p054
Oxandrolone Improves the Linear Growth and Osteoporosis in Teenage Bays with Osteogenesis Imperfecta
hrp0089p2-p055
First Reported Cases of a Novel Variant of GNAS 1 Gene
hrp0089p2-p056
An Unusual Cause of Short Stature
hrp0089p2-p057
Validation of an Automated Method (BoneXpert) for the Determination of Bone Age in Paediatric Endocrinology - A Single Centre Experience
hrp0089p2-p058
Arthrogryposis Multiplex Congenita Type II and Panhypopituitarism
hrp0089p2-p059
Bone, Growth Plate & Mineral Metabolism P3
Growth Hormone Treatment of 2 Patients with X-linked Hypophosphatemic Rickets Caused by PHEX Mutation: Effects on Linear Growth
hrp0089p3-p031
A Novel Homozygous Mutation in the CASR Gene in a Neonate with Severe Primary Hyperparathyroidism; A Case Report
hrp0089p3-p032
A 13 Year-Old Boy Diagnosed as Osteogenesis Omperfecta with Normal Bone Mineral Density
hrp0089p3-p033
A Rare Cause of Hypercalcemia in Childhood: Hypercalcemia Associated with Parathormon-Related Peptid
hrp0089p3-p034
Our Treatment Experience with Nocturnal Continuous Enteral Calcium Infusion in a Case with Vitamin D Resistance Rickets Type II
hrp0089p3-p035
A Novel COL1A2 Gene Mutation in a Turkish Family with Osteogenesis Imperfecta
hrp0089p3-p036
Hypophosphatemic Hypercalciuric Ricket: 3 Brothers with Dent's Disease
hrp0089p3-p037
Infantile Hypophosphatasia
hrp0089p3-p038
Carbonic Anhydrase Deficiency: Three Siblings
hrp0089p3-p039
A Novel p.Gly775Glu Missense COL1A2 Mutation Causes Severe Osteogenesis Imperfecta in a Prepubertal Girl
hrp0089p3-p040
SHOX Gene Deletion Screening by FISH in Children with Short Stature and Characteristics of Patients
hrp0089p3-p041
Pseudoachondroplasia
hrp0089p3-p042
Low Level of Vitamin D in Children Increases the Risk of Bone Fractures
hrp0089p3-p043
Clinical Evaluation of Eight Patients with Parathyroid Adenoma
hrp0089p3-p044
Idiopathic Hypoparathyroidism in a 10 Year-Old Girl with Concomitant Epilepsy, Long Q-T Syndrome (LQTS), Pericarditis and Pneumonia
hrp0089p3-p045
The Level of the Vitamin D and Bone Mineral Density in Children with Obesity
hrp0089p3-p046
Evaluation of Bone Mineral Density and Bone Metabolism Markers in Children Diagnosed as Celiac Disease
hrp0089p3-p047
Comparison of Serum 25-Hydroxy Vitamin D Levels among Children & Adolescence with Attention Deficit Hyperactivity Disorder and Healthy Lranian People
hrp0089p3-p048
Evaluating the Effect of Zoledronic Acid on Treatment of Primary and Secondary Pediatric Osteoporosis at Children's Hospital 1 in Vietnam
hrp0089p3-p049
Hypocalcemia Secondary to Maternal Vitamin D Deficiency
hrp0089p3-p050
Clinical and Genetic Evaluations of Three Patients with Vitamin D Dependent Rickets Type 1A
hrp0089p3-p051
A Rare Case of Familial Hypocalcemia
hrp0089p3-p052
HDR Syndrome: A Case Report of Hypoparathyroidism, Hearing Loss and Renal Agenesis
hrp0089p3-p053
Growth in The Coeliac Disease of The Child
hrp0089p3-p054
The British OsteoNEcrosis Study: A Multi-centre Prospective Study
hrp0089p3-p055
Response to Pamidronate Therapy and Pharmacogenetics in Patients with Osteogenesis Imperfecta
hrp0089p3-p056
Results of 22 Weeks of Burosumab Therapy in a Patient with Severe Bone Deformities due to XLH
hrp0089p3-p057
Severe Neonatal Hypercalcemia: A Challenging Case
hrp0089p3-p058
Assessment of Vitamin D Status in Healthy Pre-pubertal Egyptian Children
hrp0089p3-p059
Are Caucasian Children at Risk of Sub-optimal Vitamin D Levels?
hrp0089p3-p060
Incidence Rate of Vitamin D Deficiency in 12-year Old Children in Japan
hrp0089p3-p061
Idiopathic Juvenile Osteoporosis: Common Symptoms in an Uncommon Condition
hrp0089p3-p062
Abstract unavailable
hrp0089p3-p063
Hypercalcemia Associated with Increased Parathyroid Hormone-related Protein (PTHrP) in a Patient with Medulloblastoma Successfully Treated with Pamidronate
hrp0089p3-p064
A Novel Deletion Mutation in the GLUT 2 Gene in a Patient with Fanconi Bickel Syndrome
hrp0089p3-p065
A Case of Turner Syndrome with Graves' Disease and Primary Hyperparathyroidism
hrp0089p3-p066
Neonatal Hypocalcemia Revealing a Malignant Osteopetrosis
hrp0089p3-p067
Frontal Behavior Dysfunctions Revealing a Dramatic Progression of Complex Cranial Base Abnormalities in a Severe Osteogenesis Imperfecta
hrp0089p3-p068
Ionized Calcium and 25-Hydroxyvitamin D3 in Children with Steroid-sensitive Nephrotic Syndrome
hrp0089p3-p069
Hypercalcemia due to Six Newly Identified Inactivating Mutations in the CaSR Gene
hrp0089p3-p070
Diabetes & Insulin P1
Poor Metabolic Control in Children and Adolescents with Type 1 Diabetes and Psychiatric Comorbidity
hrp0089p1-p040
Concealment of Type 1 Diabetes in Adolescence Affects Adherence to Treatment, Metabolic Control, and Quality of Life
hrp0089p1-p041
Risky Behaviors of Adolescents with Type 1 Diabetes in Comparison with their Healthy Peers
hrp0089p1-p042
The Effect of Social Burden on Paediatric Diabetes Outcomes
hrp0089p1-p043
Parental Anxiety about Hypoglycemia of Children and Adolescents with Type 1 Diabetes Mellitus (T1DM) and the Associated Factors
hrp0089p1-p044
Management of Diabetes During Ramadan Fasting in Children and Adolescents: Survey of Physicians' Perceptions and Practices in the Arab Society of Paediatric Endocrinology and Diabetes (ASPED) Countries
hrp0089p1-p045
Phenotypes of Diabetes and Determinants of Glycemic Control and Diabetes Complications in Haitian Youth Living in Haiti
hrp0089p1-p046
Smoke Exposure and Cardio-metabolic Profile in Youth with Type 1 Diabetes
hrp0089p1-p047
Menstrual Cycle Disorders in Young Women with Type 1 Diabetes Mellitus
hrp0089p1-p048
Life Changing Decisions due to Etiological Genetic Diagnosis in Families of Children with Maturity Onset Diabetes of the Young (MODY)
hrp0089p1-p049
NBAS Gene Mutation Causes Insulin-Dependent Diabetes Mellitus in a Patient with a Multisystem Disorder Consisting Immunodeficiency and Extremely Short Stature
hrp0089p1-p050
Identification of Six Novel Mutations in Monogenic Diabetes and Congenital Hyperinsulinism and Detected by Targeted-Exome Sequencing in Korea
hrp0089p1-p051
Genetic Susceptibility to Type 1 Diabetes in Children: Analysis of Polymorphisms rs1990760 - IFIH1, rs20541 - IL13, rs231775 - CTLA 4
hrp0089p1-p052
Neonatal Diabetes as a First Symptom of IPEX Syndrom
hrp0089p1-p053
CpG Methylation Status Changes within the Protein Tyrosine Phosphatase Non-Receptor Type 22 Gene Promoters in Children and Adolescents of Greek Origin with Type 1 Diabetes
hrp0089p1-p054
Wolfram Syndrome Case with Hypergonadotropic Hypogonadism: A Novel Mutation
hrp0089p1-p055
Different Clinical Findings in Maturity Onset Diabetes of the Young due to B-Lymphocyte Kinase Gene Mutations
hrp0089p1-p056
Three New Gene Variants (PTPRD, SYT9, and WFS1) Related to Korean MODY Children Decrease Insulin Secretion in Human Pancreatic Beta Cells
hrp0089p1-p057
Comprehensive Genetic Testing Shows One in Five Children with Diabetes and Non-Autoimmune Extra-Pancreatic Features Have Monogenic Aetiology
hrp0089p1-p058
Impact of Diabetes During Pregnancy in Women Affected with GCK-MODY on Neonatal Health Outcome
hrp0089p1-p059
IPEX as a Result of Mutations in FOXP3 Two Case Reports and Review of the Literature
hrp0089p1-p060
The Prevalence of Autonomic and Peripheral Neuropathy in Children and Adolescents with Type 1 Diabetic Mellitus (T1D) and Its Association with the Homozygous Status of Z-2/Z-2 Polymorphism of the Aldose Reductase Gene (AKR1B1) in the Polyol Pathway
hrp0089p1-p061
Establishment of Iron Overload Insulin Cell Model and the Effect Induced by Iron Overload on Oxidative Stress
hrp0089p1-p062
Glucose Intolerance in Survivors of Childhood Hematologic Disorders
hrp0089p1-p063
Efficacy of Mecasermin Treatment and Long-Term Survival in a Child with Leprechaunism
hrp0089p1-p064
Evaluation of Diabetes Related Complications and Endothelial Dysfunction in Adolescents with Type 1 Diabetes
hrp0089p1-p065
Complexities in the Management of New-Onset Diabetes after Transplantation (Nodat) in an Adolescent with Senior-Loken Syndrome
hrp0089p1-p066
Insulin Resistance Parameters in Children Who Were Born Very Preterm and Adequate for Gestational Age
hrp0089p1-p067
Impact on Final Height of Functional Insulin-Therapy in Type 1 Diabetes Mellitus Pediatric Patients - Experience from a Portuguese Pediatric Endocrinology Unit
hrp0089p1-p068
Triglyceride Glucose Index as a Predictor of Impaired Glucose Tolerance in Overweight and Obese Adolescents
hrp0089p1-p069
Birth Weight in Offsprings of Mothers with Gestational Diabetes Mellitus due to Mutations in GCK Gene
hrp0089p1-p070
Review and Audit of Diabetes Control in Children and Young People with Diabetes Using the FreestyleLibre Flash Glucose Scanning System (FGS)
hrp0089p1-p071
Increasing Use of Continuous Glucose Monitoring (CGM) Among Youth with Type 1 Diabetes (T1D): Icomparison of Youth from the T1D Exchange (T1DX) and the DPV Initiative
hrp0089p1-p072
Efficacy of Real-time Continuous Glucose Monitoring in Type 1 Diabetic Pre-school and School Children Treated with Multiple Daily Injections
hrp0089p1-p073
Catheter Site Selection and Anthropometric Measurements at Subjects with Type 1 Diabetes and Continuous Subcutaneous Insulin Infusion
hrp0089p1-p074
Open Source Artificial Pancreas Systems Used from Bulgarian Children and Young People with Diabetes
hrp0089p1-p075
National Survey of Usage of Continuous Glucose Monitoring in Children and Adolescents at Non Reimbursed Setting
hrp0089p1-p076
Additional Insulin is Necessary to Prevent Rise in Blood Glucose after Fat-protein-rich Meals in Type 1 Diabetes
hrp0089p1-p077
Efficacy of Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Childhood Type 1 Diabetesefficacy of Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Childhood Type 1 Diabetes
hrp0089p1-p078
A Novel SLCA16A1 Mutation in an Infant with Hypoglycemia and Severe Metabolic Ketoacidosis
hrp0089p1-p079
Successful Transition to Sulfonylurea Therapy in Infant with Neonatal Diabetes, Developmental Delay, Epilepsy (DEND Syndrome) due to F132L ABCC8 Mutation
hrp0089p1-p080
ZFP57-associated Transient Neonatal Diabetes is Responsive to Oral Sulfonylurea Treatment
hrp0089p1-p081
The Comparison of the Occurrence of Beta Cells Autoantibody and Regulatory T Cells (CD4+CD25+FoxP3+) in Patients with Type 1 Diabetes Mellitus, their Siblings and Healthy Children
hrp0089p1-p082
HERV-W-Env Protein Expression in Pediatric Type 1 Diabetes Patients
hrp0089p1-p083
The Comparison of the Occurrence of Beta Cells Autoantibody and Natural Killer Cells in Patients with Type 1 Diabetes Mellitus, Their Siblings and Healthy Children
hrp0089p1-p084
T- and B-Lymphocytes Levels in Children with Type 1 Diabetes in Association with Candida Infection
hrp0089p1-p085
Coincidence of Newly Diagnosed Type 1 Diabetes Mellitus with Enteroviruses and Respiratory Tract Viruses
hrp0089p1-p086
Investigation into [beta]-cell Adaptation During Puberty
hrp0089p1-p087
The Shape of the Glucose Curve and Time to Glucose Peak During an Oral Glucose Tolerance Test as Indicators of Beta Cell Function in Obese Adolescents
hrp0089p1-p088
Features of T2DM in Adolescents with Low Titer of ICA and IAA
hrp0089p1-p089
Increasing Trend of Fasting Plasma Glucose Levels and Impaired Fasting Glucose in Non-Diabetic Korean Youth and Young Adults: A Nationally Representative Population-Based Study
hrp0089p1-p090
Screening for T2D in High Risk Egyptian Children and Adolescents Using Strip HbA1c and OGTT
hrp0089p1-p091
Association of the Sizes and Composition of HDL with Hepatic Steatosis in Adolescents with Type 2 Diabetes (T2D)
hrp0089p1-p092
Diabetes & Insulin P2
Incidence of Childhood Type 1 and Type 2 Diabetes Mellitus in Qatar between 2012-2016
hrp0089p2-p060
The Prevalence of Double Diabetes in Children and Adolescents in Qatar
hrp0089p2-p061
Prevalence of Diabetes Type 1 and Type 2 in Children and Adults in Kazakhstan in 2016
hrp0089p2-p062
Detection of the Pathogenic Genes in the Diagnosis and Treatment of Hyperglycemia Infants and Children
hrp0089p2-p063
Early Diagnosis of Diabetes Type 2 in Children with Progeria Syndromes
hrp0089p2-p064
Transient Neonatal Diabetes Mellitus due to not Described Mutation in ABCC8 Gene with Different Behaviour in Affected Family Members
hrp0089p2-p065
Prothrombin Gene 20210A Mutation Heterozygosity and MTHFR Gene C677T Mutation Homozygosity Detected in a Male Toddler Experiencing Femoral Venous Thrombosis During Diabetic Ketoacidosis
hrp0089p2-p066
Frequency of Occurrence of MODY in the Population of Diabetic Patients in St. Petersburg
hrp0089p2-p067
Acute Painful Diabetic Neuropathy (Apdn) in a Boy with Type 1 Diabetes
hrp0089p2-p068
Features of Japanese Patients with Early-Onset, Mody-Like Diabetes without Mutations in the Major Mody Genes
hrp0089p2-p069
Frequency and Etiologic Spectrum of Monogenic Diabetes in Pediatric Diabetes in a Single Academic Center
hrp0089p2-p070
Clinical Details, Molecular Genetic Analysisand Clinical Pheonotype Correlation of 14 Patients with Neonatal Diabetes from The South India - A Single Centre Experience
hrp0089p2-p071
Syndromic Patients with Negative Islet Autoantibodies should be Tested for Mongenic Diabetes: Lessons from Patient with Trmt10a Mutation
hrp0089p2-p072
A Novel Mutation in Phka2: Idiopathic Ketotic Hypoglycaemia May Represent Mild Gsdixa
hrp0089p2-p073
The Application of Next Generation Sequencing Mody Gene Panel in Greek Patients
hrp0089p2-p074
Type 5 Monogenic Diabetes: Reportof 7 Cases
hrp0089p2-p075
Novel Gata6-Mutation in a Boy with Neonatal Diabetes and Diaphragmatic Hernia
hrp0089p2-p076
Clinical and Genetic Characterizations of Maturity Onset Diabetes of the Young: Single Center Results
hrp0089p2-p077
Protein and Fat Effects on Post - Prandial Glucose Responses among Egyptian Children and Adolescents with Type 1 Diabetes Mellitus
hrp0089p2-p078
Amino Acids Plasma Profile in Children with Type 1 Diabetes
hrp0089p2-p079
Betatrophin as a New Biomarker of Type 1 Diabetes Mellitus in Paediatrics
hrp0089p2-p080
Vitamin D Status among Children and Adolescent with T1DM
hrp0089p2-p081
IGF-1 Relationship with Growth Velocity in Precocious Puberty with GnRHa Treatment
hrp0089p2-p082
Relation between Hypomagnesemia and Increased Level of HbA1c in Patients with Diabetes Mellitus
hrp0089p2-p083
PID1 Alters Antilipolytic Action of Insulin and Increases Lipolysis via Inhibited the Activation of AKT/PKA Pathway
hrp0089p2-p084
The Efficacy of Tri-ponderal Mass Index and Body Mass Index in Estimating Insulin Resistance, Hyperlipidemia and Impaired Liver Enzymes During Childhood and Adolescents
hrp0089p2-p085
Local Experience of Diabetes and Deafness
hrp0089p2-p086
Translating the A1C Assay into Estimated Average Glucose Values in Children with Type 1 Diabetes Mellitus
hrp0089p2-p087
Relationship Between Residual Endogenous Insulin Secretion and Glycemic Control in Japanese Children and Adolescents with Type 1 Diabetes
hrp0089p2-p088
A Curious Case of Persistent Lactic Acidosis in a Child with Diabetic Ketoacidosis
hrp0089p2-p089
An Unusual Case of an Exclusively Vegan Child with Diabetic Acidosis
hrp0089p2-p090
HLA-DQ Genotyping in Patients with Type 1 Diabetes Mellitus and Celiac Disease
hrp0089p2-p091
Hypertriglyceridemia in Type 1 Diabetes Children During Diabetic Ketoacidosis; Relation to DKA Severity and Glycemic Control
hrp0089p2-p092
Acute Mononeuropathy in an 8-Year-Old-Girl with Newly Diagnosed Type 1 Diabetes
hrp0089p2-p093
HLA-G Gene Promoter Methylation Status in Children and Adolescents with Type 1 Diabetes
hrp0089p2-p094
Impaired Adrenal Function in Pediatric Patients with Diabetes Mellitus Type 1 Evaluated with Low-Dose Synacthen Test
hrp0089p2-p095
The Incorporation of Available Technologies for Diabetes Care Among Different Worldwide Centers: The ESPE/ISPAD Working Group on Diabetes Technology Survey
hrp0089p2-p096
Higher Percentage of Insulin Pump Users at Isle of Man (IOM) - Two Years Observational Data
hrp0089p2-p097
Use of Continuous Glucose Monitoring Systems in the Early Detection And Management of Cystic Fibrosis Related Diabetes in Children
hrp0089p2-p098
Metabolic Improvement Offered by Medtronic Minimed 640 G Associated to Transient Insulin Perfusion Suspension before Hypoglycemia in Young Patients with Type 1 Diabetes
hrp0089p2-p099
The Glycemic Variability in Children with Diabetes Mellitus
hrp0089p2-p100
The Levels of Blood Glucose and Counting of Carbohydrate-Fat-Protein in Diabetic Children Using Pump with Aspart and Glulisine
hrp0089p2-p101
A Novel Missense Variant, p.(Thr405Arg), in the SLC19A2 Gene in an Infant with Thiamine Responsive Megaloblastic Anemia Syndrome Presenting with Anemia and Diabetes but with Normal Hearing
hrp0089p2-p102
Donohue Syndrome with Hypertrophic Cardiomyopathy
hrp0089p2-p103
Age and Exocrine Pancreatic Enzyme Requirements are Major Determinants for Carbohydrate Metabolism Impairment in Children Affected with Cystic Fibrosis
hrp0089p2-p104
Post-Prandial Hyperinsulinaemic Hypoglycaemia after Oesophageal Surgery in Children
hrp0089p2-p105
Congenital Hyperinsulinism: Clinical and Molecular Characteristics - Fluorine-18-L-Dihydroxyphenylalanine Positron Emission Tomography (F-DOPA PET) Scan Results - Treatment Responses and Short Term Outcomes of 5 Patients
hrp0089p2-p106
Congenital Hyperinsulinism in a Child with Alagille Syndrome
hrp0089p2-p107
Severe Stress-Induced Subcutaneous and Intravenous Insulin Resistance in an Eight Year Old Boy with T1DM, Necessitating Seven Months of IV Insulin, Reversed after Psychiatric Treatment
hrp0089p2-p108
A Case of Neonatal Diabetes Due to Pancreatic Hypoplasia
hrp0089p2-p109
Neonatal Diabetes Mellitus Caused by a Novel GLIS3 Mutation in Twins
hrp0089p2-p110
Permanent Neonatal Diabetes, Hepatic Failure and Progressive Left Hemispheric Cerebral Atrophy in a Patient with Wolcott-Rallison Syndrome: A Clinical and Genetic Study from the State of Qatar
hrp0089p2-p111
A Rare Case of Diabetes Mellitus Type 1 in a Child with Neurofibromatosis Type 1
hrp0089p2-p112
Detection and Analysis of Glycometabolism Related Genes in Children Diabetes
hrp0089p2-p113
Gender Characteristics of Responsibility for Their Own Health of Adolescents with Type I Diabetes Mellitus
hrp0089p2-p114
Favorable Outcome Despite Prolonged Hypoglycemic Episodes Following a Massive Insulin Overdose: A Case Series
hrp0089p2-p115
Effect of a Reduced Fluid Replacement Regimen on the Resolution of Diabetic Ketoacidosis (DKA) in Children
hrp0089p2-p116
Prevalence of and Risk Factors for Nonadherence to Insulin Among Paediatric Type 1 Diabetes Patients in Singapore
hrp0089p2-p117
[ldquo]What do You Know About Your Diabetes?': A Qualitative and Quantitative Study of Teenagers and Young Adults' Understanding of their Disease
hrp0089p2-p118
Parental Knowledge and Attitudes Toward Diabetes Mellitus Type 1: A Cross Sectional Study
hrp0089p2-p119
Identifying the Association of Depression and Diabetic Distress in Pakistani Patients Diagnosed with Type 1 Diabetes
hrp0089p2-p120
Role of Breastfeeding in Prevention of Type 1 Diabetes in Pakistan
hrp0089p2-p121
A Young Type 1 Diabetic with Acute Hemichorea: Rare Central Nervous System Complications
hrp0089p2-p122
Diabetes & Insulin P3
Multiple Autoimmune Association and Varied Spectrum of Presentation in Indian Diabetic Children
hrp0089p3-p071
Severe Hypertriglyceridemia and Multiple Autoimmune Phenomenon at new onset Type 1 DM
hrp0089p3-p072
Effects of Diabetes Mellitus Type-1 on Vitamin D Status Among Children
hrp0089p3-p073
Association between Prior Toxic Stressors and Development of T2DM in Adolescents
hrp0089p3-p074
First Four Cases of Neonatal Diabetes from Kazakhstan, Almaty with Proven Mutations in KCNJ11 and INS Genes
hrp0089p3-p075
First 2 Cases of Monogenic Diabetes (MODY) from Kazakhstan, Almaty with Proven Heterozygous Mutation in Hepatocyte Nuclear Factor 1-Alpha (HNF1A) Gene
hrp0089p3-p076
Achievement of Therapy Targets in Children and Adolescents with Type 1 Diabetes Mellitus at the 'Diabetes School'
hrp0089p3-p077
Characteristics of MODY-GCK Diabetes in Children and Adolescents in Siberia
hrp0089p3-p078
Clinical Case of MODY-GCK Diabetes: Heterogeneity of Course among Relatives from One Family
hrp0089p3-p079
Clinical and Biochemical Characteristics of Familial Type 1 Diabetes Mellitus (FT1DM) Compared to Non-Familial Type 1 DM (T1DM)
hrp0089p3-p080
Prevalence of Beta-cell Antibodies and Associated Autoimmune Diseases in Children and Adolescents with Type 1 (T1DM) vs Type 2 Diabetes Mellitus (T2DM) in Qatar
hrp0089p3-p081
Clinical Presentation and Autoimmune Markers in Children and Adolescents with Familial Type 1 Diabetes Mellitus (FT1DM) and Familial Type 2 Diabetes Mellitus (FT2DM)
hrp0089p3-p082
Real-world Clinical Evolution of Type 1 Diabetes Patients on Twenty Years
hrp0089p3-p083
Diabetic Capilaropathy: A Case Report
hrp0089p3-p084
A Sibling Case of Wolfram Syndrome with Diabetes Mellitus Diagnosed within 10 Months in Early Childhood
hrp0089p3-p085
Continuous Subcutaneous Insulin Infusion in Children and Adolescents: Analysis of Initial and Follow Up Basal Rates
hrp0089p3-p086
Prevalance of Fatty Liver in Patients with Type 1 Diabetes Mellitus Attending Diabetes Clinic at Alexandria University Children's Hospital
hrp0089p3-p087
The Triad of Obesity, Acanthosis Nigricans and Diabetes Mellitus in a Newly Diagnosed Adolescent; Is This Type 1 Or Type 2 Diabetes Mellitus?
hrp0089p3-p088
A Female Patient with Atypical Diabetes Features, Showing Heterozygous Mutations on G6PC2 (Glucose 6 Phosphatase, Catalytic Subunit 2): Does Explain All Clinical Manifestations or Is It Only Polymorphism?
hrp0089p3-p089
Clinical and Laboratory Features at the Onset of Childhood Type 1 Diabetes Mellitus in the Nortwest Region (Trakya) of Turkey
hrp0089p3-p090
Clinical and Epidemiological Features of Children with Type 1 Diabetes
hrp0089p3-p091
Predictors of Optimal Glycemic Control in Children with Diabetes Mellitus Type 1 Receiving Pump Insulin Therapy
hrp0089p3-p092
Symptomatic Cerebral Infarction: A Rare Complication of Diabetic Ketoacidosis
hrp0089p3-p093
Our Clinical Experiences in Type 2 Diabetes
hrp0089p3-p094
The Relationship between Serum Levels of C-Peptide and the Age, BMI, and Insulin Doses in Reply to: Newly Diagnosed Type 1 Diabetic Children
hrp0089p3-p095
Serum Trace Element Levels in Children Presenting with Diabetic Ketozis and Diabetic Ketoacidosis: A Longitudinal Controlled Study
hrp0089p3-p096
Evaluation of Relation between Diabetic Education Levels of Type 1 DM Child/Adolescent and Parents and Metabolic Control
hrp0089p3-p097
A Case of Childhood Type 1 Diabetes Mellitus Who Developed Granuloma Annulare
hrp0089p3-p098
Case Report: De Novo Mutation of Foxp3 Causing Mild Phenotype of Immunodysregulation, Polyendocrinopathy, Enteropathy, X-Link Syndrome
hrp0089p3-p099
Is There a Relationship between Immune-Mediated Type 1 Diabetes Mellitus and Congenital Rubella Infection?
hrp0089p3-p100
Changes in Glycemic Control after Switching from NPH & RI to Insulin Glargine and Lispro in Children with Type 1 Diabetes Mellitus (T1DM)
hrp0089p3-p101
When Type Mody Ii Diabetes Simulates Type I Diabetes
hrp0089p3-p102
Epidemiological Study and Analysis of Type 1 Diabetes Comparing Patients with and Without Ketoacidosis in the Last 5 Years
hrp0089p3-p103
The Frequency of Diabetic Ketoacidosis Hospitalization in Siberian Children and Adolescent
hrp0089p3-p104
Monogenic Diabetes Cause by Mutation of the Gene HNF-1A
hrp0089p3-p105
Reversibility of Early Acute Diabetic Neuropathy (DN) in Adolescents with Type 1 Diabetes Mellitus (T1D)
hrp0089p3-p106
The Value of Continuous Hemodiafiltration in Rescuing Children with Severe Diabetic Ketoacidosis
hrp0089p3-p107
Psychosocial Risks, Comorbidities and Health Events During the Follow-up of Children and Adolescents with Type 1 Diabetes
hrp0089p3-p108
Clinical Profile and Outcome of Diabetic Ketoacidosis in a Tertiary Care Teaching Hospital of a Developing Country
hrp0089p3-p109
Diabetes Mellitus, Autoimmune Hemolytic Anemia, Hepatosplenomegaly and Lymphadenopathy: A Rare Association in Chinese Children
hrp0089p3-p110
Type 1 Diabetes and Central Precocious Puberty a Rare Association
hrp0089p3-p111
Diabetic Ketoacidosis among Egyptian Children with Type 1 Diabetes: 3-Years Study
hrp0089p3-p112
Fructosamine Level in Type 1 Diabetes Mellitus Children Performing Ramadhan Fasting
hrp0089p3-p113
Metformin Therapy Ina Lean Adolescent Girl with Prediabetes Dysglycemia Treated: Good Response
hrp0089p3-p114
Association between Thyroid Stimulating Hormone and Hemoglobine A1c in Type 1 Diabetes Mellitus Children
hrp0089p3-p115
Monogenic Diabetes in 2 Years and 4 Months Old Girl: Is it DEND?
hrp0089p3-p116
Compliance for Monitoring of Glycemic Control in Children with Type 1 Diabetes
hrp0089p3-p117
Ketogenic Diet in a Child with Diabetes and Global Developmental Delay
hrp0089p3-p118
A Rare Cause of Severe Anemia in a Patient with Type 1 Diabetes
hrp0089p3-p119
Oral Gliclazide (A Sulfonylurea) Monotherapy is Effective and Safe in the Management of T2DM in Children: A Case Report
hrp0089p3-p120
Pediatric Stroke as the Presenting Symptom of New Onset Diabetes without DKA
hrp0089p3-p121
Challenges in Educating New Onset Type 1 Diabetes Mellitus Patients: Can the Use of a Tablet be the Answer?
hrp0089p3-p122
AID-GM System (Advanced Intelligent Distant - Glucose Monitoring) to Monitor Health Status and Metabolic Control of Young People with Type 1 Diabetes
hrp0089p3-p123
Continuous Glucose Monitoring Results of Our Cases with MODY Type 2 Diabetes
hrp0089p3-p124
Family Investigation and Clinical Phenotype Analysis of Type A Insulin Resistance Syndrome
hrp0089p3-p399
Epidemiology, Demographic Criteria and Risk Factors in Type 1 DM Egyptian Children; A Single Center Study
hrp0089p3-p403
Degludec Versus Glargine in Pediatric and Adolescent Patients with Type 1 Diabetes
hrp0089p3-p407
A Rare and Unexpected Cause of Diabetes in Childhood
hrp0089p3-p416
Study of Children with Type 1 Diabetes Mellitus of Long Duration Attending Alexandria University Children'S Hospital
hrp0089p3-p417
Abstract unavailable
hrp0089p3-p419
Fat, Metabolism and Obesity P1
Functional Characterization of Novel and Known Genetic Variants in the Leptin Receptor (LEPR) Gene of Two Patients with Morbid Obesity
hrp0089p1-p093
Association of Single Nucleotide Polymorphisms in TNFA, PNPLA3, ADIPOQ and APOC3 Genes with Obesity and Non-Alcoholic Fatty Liver Disease in North Indian Adolescents
hrp0089p1-p094
Variation of Circulating Brain-Derived Neurotrophic Factor According to Gender, Body Mass Index and Metabolic Syndrome Parameters in Adolescents
hrp0089p1-p095
Kisspeptin and the Genetic Obesidome
hrp0089p1-p096
Circulating Exosomal miRNAs Involved in the Pathogenesis of Children Nonalcoholic Steatohepatitis
hrp0089p1-p097
Placental Fatty Acid Profile, DNA Methylation and Adverse Metabolic Outcomes in the Offspring at School Age
hrp0089p1-p098
Association of Serum Fibroblast Growth Factor 21 and Irisin with Insulin Sensitivity Markers and Serum Lipids in 12-year-old Children
hrp0089p1-p099
Serum Catestatin Levels in Obese Children and Adolescents
hrp0089p1-p100
Circulating Mots-C Levels are Decreased in Obese Male Children and Adolescents and Associated with Insulin Resistance
hrp0089p1-p101
Plasma Adropin Levels are Associated with Lipid Characteristics Amongst Children with Obesity
hrp0089p1-p102
Associations of Non-High-Density Lipoprotein Cholesterol with Metabolic Syndrome and Its Components in Korean Children and Adolescents: the Korea National Health and Nutrition Examination Surveys 2008-2014
hrp0089p1-p103
Chromosomal Deletions at Chromosome 16p11.2 Associated with Severe Early-Onset Obesity- 3 Additional Patients
hrp0089p1-p104
Effect of a Melanocortin-4 Receptor (MC4R) Agonist, Setmelanotide, on Obesity and Hyperphagia in Individuals Affected by Alstrom Syndrome
hrp0089p1-p105
Towards a Greater Understanding of the Pathophysiology of Obesity: Hypothalamic Obesity as a Model of Dysregulation of Appetite and Metabolic Homeostasis
hrp0089p1-p106
Serum Uric Acid Level and Its Association with Metabolic Syndrome in Korean Adolescents
hrp0089p1-p107
More than A Gut Feeling: Preliminary Evidence Supporting a Role for Lifestyle Habits in Shaping the Intestinal Microbiota in Childhood and Adolescence
hrp0089p1-p108
Efficiency of Alpha-lipoic Acid in Metabolic Syndrometreatment in Children
hrp0089p1-p109
Lipid Accumulation Product is a Predictor of Non-alcoholic Fatty Liver Disease in Childhood Obesity
hrp0089p1-p110
Selected Serum Adipokines in Children with Irritable Bowel Syndrome
hrp0089p1-p111
Role of Urinary NGAL and KIM-1 as Early Kidney Injury Biomarkers in Obese Prepubertal Children
hrp0089p1-p112
Maternal Resveratrol Intake During Pregnancy and Lactation Modulates the Long-term Metabolic Effects of Maternal Nutrition on Offspring Depending on the Sex and Diet
hrp0089p1-p113
Intrauterine Metformin Exposure and Offspring Metabolic Health at 8-Years Follow-up
hrp0089p1-p114
Greater Maternal BMI Early in Pregnancy and Excessive Gestational Weight Gain are Independently Associated with Adverse Health Outcomes in the Offspring at Age 7 Years
hrp0089p1-p115
Rapid BMI Gain During Later Infant Accelerates Skeletal Maturation at Prepubertal Obese Children
hrp0089p1-p116
The More Obese - The Less Pubertal Height Gain
hrp0089p1-p117
Longitudinal Changes in Abdominal Fat Distribution in the First Two Years of Life
hrp0089p1-p118
Telemedicine Therapy for Overweight Adolescents: First Results of a Novel Smartphone App Intervention Using a Behavioural Health Platform
hrp0089p1-p119
Cardiorespiratory Fitness Effectiveness is Related to Abdominal Adiposity and Insulin Sensitivity in Overweight Adolescents
hrp0089p1-p120
Promoting Healthy Lifestyles in Youth: Preliminary from the CIRCUIT Program
hrp0089p1-p121
Determinants of Attrition from a Healthy Lifestyle Intervention: Experience from the CIRCUIT Program
hrp0089p1-p122
Interleukin-6 Levels are Associated with High Blood Pressure and Low HDL Cholesterol in Healthy 4-year-old Children
hrp0089p1-p123
Metabolic Phenotype of Human Adipocytes Overexpressing UCP1
hrp0089p1-p124
M2 Macrophage Markers are Enriched in Human Deep Neck Adipose Tissue and Do Not Correlate with UCP1 Expression
hrp0089p1-p125
Effect of Hormonal Changes on Exocrine Pancreatic Function in Girls with Anorexia Nervosa
hrp0089p1-p126
PCSK9 and Lp(a) Levels of Children Born after Assisted Reproduction Technologies
hrp0089p1-p127
Rate of Accumulation of Abdominal Fat is Associated with Fasting Glucose Levels in Early Childhood
hrp0089p1-p128
Early Menarche is Associated with Insulin Resistance and Non-Alcoholic Fatty Liver Disease in Obese Adolescents
hrp0089p1-p129
The Frequency of Obstructive Sleep Apnea in Children with Hypothalamic and Exogenous Obesity
hrp0089p1-p130
The Importance of Universal Lipid Profile Screening in Two to Ten Years Old Lebanese Children
hrp0089p1-p131
Non-Invasive Measurements of Central Blood Pressure with Arterial Stiffness Indicators as a New Research Tool for Predicting Cardiovascular Risk in Children with Type 1 Diabetes Mellitus and Obesity
hrp0089p1-p132
Severe Obesity and Cardiometabolic Comorbidities in Adolescents: Chronology of an Epidemic
hrp0089p1-p133
Evaluation of Intraocular Pressure and Retinal Nerve Fiber Layer, Retinal Ganglion Cell, Central Macular Thickness and Choroidal Thickness Using Optical Coherence Tomography in Obese Children and Healthy Controls
hrp0089p1-p134
Fat, Metabolism and Obesity P2
Allopurinol Ameliorates Non-Alcoholic Fatty Liver Disease in Rats
hrp0089p2-p123
Relationships of Dietary Intake and Sugar Rich Products Consumption with Hepatic Fat Content and Insulin Resistance among Children with Overweight/Obesity: The PREDIKID Study
hrp0089p2-p124
Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphism in Egyptian Obese Children and Adolescents: Relation to Hypertension Risk
hrp0089p2-p125
Serum Calprotectin Level in Children: Marker of Obesity and Its Metabolic Complications
hrp0089p2-p126
Pediatric Continuous Metabolic Syndrome Score (PsiMS score): Use in Everyday Clinical Practice
hrp0089p2-p127
Leptin and Cytokines are Not the Best Markers for Metabolic S
hrp0089p2-p128
Early-Life Risk Factors and Their Association with Hypertension in Spanish Children and Adolescents
hrp0089p2-p129
A Rare Case of Diabetes Mellitus in an Adolescent: Partial Lipodystrophy
hrp0089p2-p130
Visfatin, RBP4 and STRA6 polymorphisms' in relation with Childhood Obesity
hrp0089p2-p131
Characteristics of Blood Lipids in Boys with Hypoandrogenia
hrp0089p2-p132
Tri-Ponderal Mass Index: A Good Anthropometric Index to Evaluate Adiposity in Children and Adolescents
hrp0089p2-p133
Serum Spexin Concentrations in Adolescent Females with Metabolic Syndrome, Polycystic Ovary Syndrome and Anorexia Nervosa
hrp0089p2-p134
A Simple Relaxation Exercise Reduces Stress in Obese Youth - A Path to a Healthy Lifestyle?
hrp0089p2-p135
Dyslipidemia and Its Related Factors in Chinese Children and Adolescents with Turner Syndrome
hrp0089p2-p136
Severity, Duration and Phenotype of Obesity Promote Precocious Cardiovascular Sonographic Alterations in Childhood Obesity
hrp0089p2-p137
Physical Activity Determined by Accelerometry Before and After an Integral Treatment Program in Children with Abdominal Obesity
hrp0089p2-p138
The Associations Between Neck - and Upper Arm Circumference with Cardiometabolic Risk Over Traditional Risk Factors in Adolescents - Data from Five EUROPEAN Countries (PreSTART-Study)
hrp0089p2-p139
Sex-related Differences and Effect of Puberty on Metabolic Syndrome in Obese Children and Adolescents
hrp0089p2-p140
Associations between Total Leptin, Bio-inactive Leptin, Soluble Leptin Receptor and Anthropometrics in Children with Severe Early-onset Obesity (SEOO) - the German-Polish Study (EOL-GPS)
hrp0089p2-p141
Children with Obesity are Taller in Early Childhood with Subsequent Catch-down Growth Until Adolescence
hrp0089p2-p142
The Relationship between Anthropometric Measurements and Breast Milk Ghrelin and Nesfatin-1 Levels in Infants with Small for Gestational Age
hrp0089p2-p143
Efficacy, Safety and Tolerability of Liraglutide, GLP-1 Analogue, in Indian Adolescent Population with Obesity
hrp0089p2-p144
The Effect of Exclusive Breastfeeding and Formula Feeding on Body Composition During the First Two Years of Life
hrp0089p2-p145
Body Composition and Cardiovascular Function in Pre-adolescent Children of South Asian and White European Origin: Relationship to Maternal Status in Pregnancy
hrp0089p2-p146
Relation Between Cardiac Function and Anthropometric Parameters in Overweight and Obese School Boys
hrp0089p2-p147
Evaluation of Hydration Status of Obese Children - A Pilot Study
hrp0089p2-p148
Galanin is Positively Correlated with Insulin Resistance and Triglyceride Levels in Obese Children
hrp0089p2-p149
Brown Adipose Tissue in Prepubertal Children: Associations with Sex and With the Sequence of Prenatal Growth Restraint and Postnatal Catch-up
hrp0089p2-p150
The Age of Pubertal Onset Correlates with Pubertal Growth Pattern and Body Weight Change in Girls
hrp0089p2-p151
Does Late Sleeping Time Results Increased Bedtime Snack? What is the Risk of this in Childhood Obesity?
hrp0089p2-p152
Early BMI Trajectory Classes are Linked to Distinct Body Fat Partitioning Later in Childhood
hrp0089p2-p153
Hair Cortisol Concentrations in Overweight and Obese Children and Adolescents
hrp0089p2-p154
Associations between Body Fat Mass and Internalizing and Externalizing Behaviors and Anxiety in Children and Adolescents
hrp0089p2-p155
Pharmacotherapy and the Effects on LDL Levels and Growth in 2 Children with Severe Familial Hypercholesterolemia
hrp0089p2-p156
Brown Tumors in Children on Hemodialysis
hrp0089p2-p157
The Role of Fibroblast Growth Factor 21 and Irisin in the Pathogenesis of Obesity in Childhood and Adolescence
hrp0089p2-p158
Serum NAMPT Levels are not Associated with Parameters of Liver Function in Children and Adolescents
hrp0089p2-p159
Obesogenic Environment and Their Influence on Adiposity on Mexican Children and Adolescents
hrp0089p2-p160
Metabolic Alterations and Weight Status in Children at 8 Years: A Prospective Cohort Study
hrp0089p2-p161
Correlation of Dietary Habits with Systolic Blood Pressure in Healthy Children
hrp0089p2-p162
Evaluation of Voiding Dysfunction in Obese Children
hrp0089p2-p163
Comparison of Antropometric and Biochemical Parameters in Obese Children with or without Primary Headache
hrp0089p2-p164
The Protective Effect of Exclusive Breastfeeding for overweight/Obesity in Children with High Birth Weight
hrp0089p2-p165
Determinants and Consequences of Exaggerated Adrenarche in Simple Obesity
hrp0089p2-p166
Metabolic Alteration in Patients Affected by PseudoHypoParathyroidismo 1a (PHP1a): A Preliminary Data
hrp0089p2-p167
Weight Loss Outcomes in Two-Year Multidisciplinary Lifestyle Intervention Program Involving Obese Children and their Parents
hrp0089p2-p168
Relationship between Glucose and Lipid Metabolism, Inflammatory Factors and Adipokines in Children with Obesity
hrp0089p2-p169
Development of Resistance to Sorafenib, a Multikinase Inhibitor, in Hepatocellular Carcinoma is Mediated by SIRT
hrp0089p2-p170
Gender and Pubertal Tendencies of Plasma leptin and Dopamine Levels Depending on TaqIA DRD2 Gene Polymorphism in the Different Pediatric Obesity Classes
hrp0089p2-p171
Iron Metabolism Disorders in Prepubertal Obese Children with and Without NAFLD
hrp0089p2-p172
Familial Hypercholesterolemia Due to Homozygous LDLRAP1 Mutation: Variability of Phenotype and Response to Medical Therapy
hrp0089p2-p173
CAN Triponderal Mass Index be a New Indicator in the Predicting Cardiometabolic Risk in Obese Adolescents?
hrp0089p2-p174
Social Networks, Social Support and Weight-Related Outcomes among Adolescents
hrp0089p2-p175
Identification of A Novel Homozygous Mutation in BBS10 in Five Children With Bardet-Biedl Syndrome
hrp0089p2-p176
The Effects of the Birth Weight on the Fat Distribution and Fatness Parameters of the Body
hrp0089p2-p177
Oxidative Homeostasis Dysregulation May Promote Pathogenesis of Cardio-metabolic Complications in Childhood Obesity
hrp0089p2-p178
Body Composition Parameters, Systemic Inflammation and Metabolic Syndrome Manifestations in Children and Adolescents
hrp0089p2-p179
Relationships between Obesity Parameters and Urinary Concentrations of Phthalates and Phenols in Korean Girls
hrp0089p2-p180
Fat, Metabolism and Obesity P3
NKX2-2 Human Mutation Causes Neonatal Diabetes followed by Severe Infantile Obesity Associated with Paradoxical Upregulated Ghrelin Levels - Do Beta-cells Secrete Ghrelin?
hrp0089p3-p125
Tracing the Effect of the Melanocortin-4 Receptor Pathway in Obesity: Study Design and Methodology of the TEMPO Registry
hrp0089p3-p126
BigO: Big Data Against Childhood Obesity
hrp0089p3-p127
Exposure to Bisphenol-A and Phtalates in Obese Girls
hrp0089p3-p128
Obesity of Childhood and Ambulatory Glucose Monitorization
hrp0089p3-p129
Familial Partial Lipodystrophy, Importance of Family History - A Case Report
hrp0089p3-p130
Development of Severe Obesity in a Children with a Brainstem Tumor
hrp0089p3-p131
Correlation Between Obesity, BMI and Insulin Resistance in Bulgarian Children
hrp0089p3-p132
Nonclassical Manifestation of PWS
hrp0089p3-p133
Metabolic Parameters in Children with Syndromic Obesity
hrp0089p3-p134
Cut-off for the Follow-up of Obese Children: Cynicism or Realism?
hrp0089p3-p135
Proximal Microdelection 16p11.2 Syndrome
hrp0089p3-p136
The Level of the Vitamin D and Metabolic Status in Children with Obesity
hrp0089p3-p137
A Compound Heterozygote Mutation in a Chinese Patient Affected with Methylmalonic Acidemia
hrp0089p3-p138
Lymposomal Acid Lipase Deficit in Patients with Hypercholesterolemia
hrp0089p3-p139
Hepatic Steatosis and its Relationship with the Metabolic Syndrome
hrp0089p3-p140
Serum Hepcidin and Ferritin in Prepubertal Obese Children
hrp0089p3-p141
Osse Registry for Patients with Lipodystrophy Run by the European Consortium of Lipodystrophy (ECLip)
hrp0089p3-p142
Acanthosis Nigricans in Obese Children and Adolescents in relation to Severity of Obesity and Insulin Resistance
hrp0089p3-p143
Serum Uric Acid and Its Correlation with Metabolic Syndrome Factors in Simple Obesity Children
hrp0089p3-p144
Thyroid Function, Lipid Profile and Carbohydrate Metabolism Parameters in Patients with Alstrom Syndrome
hrp0089p3-p145
Does the Level of Studies of Parents Influence the Follow-up of the Recommendations of the Nutritional Pyramid?
hrp0089p3-p146
Bariatric Surgery as Treatment of Primary Pseudotumor cerebriin a Male Adolescent: Case Report
hrp0089p3-p147
Investigation of Pubertal Effect on Thyroid Volume and IGF-1 Changes in Morbid Obese Children
hrp0089p3-p148
The Effect of Vitamin D Supplementation on Metabolic Syndrome Parameters in Overweight and Obese Children and Adolescents in Greece
hrp0089p3-p149
Mother's Obesity and High Child's Waist Circumference are Predictive Factors of Severe Child's Obesity: An Observational Study in French Guiana
hrp0089p3-p150
Lipidogram, Leptin-and Adiponectinaemia in Teenagers and Adolescents with Metabolic Syndrome
hrp0089p3-p151
Metabolic Endotoxemia in Egyptian Obese Children and Adolescents
hrp0089p3-p152
Resting Metabolic Rate and the Development of Metabolic Disorders in Obese Children
hrp0089p3-p153
Relation of Screen-Time (Phone-Computer-TV-Online Games) and Physical Activity with Childhood Obesity
hrp0089p3-p154
Effect of Three-Month Diet and Physical Activity on Adipokines and Inflammatory Status in Children with Metabolic syndrome
hrp0089p3-p155
Neck Circumference and Lipid Profile in Adolescents with Overweight/Obesity
hrp0089p3-p156
A Not So 'Simple Obesity'
hrp0089p3-p157
Effect of Obesity on Bone Age and Hormonal Parameters in Indian Children
hrp0089p3-p158
Compliance of Obese Children and Their Family to the Directions of a Pediatric Endocrinology Medical Office
hrp0089p3-p159
Risk Factors and Comorbidities of Childhood Obesity
hrp0089p3-p160
Autonomic Nervous System - Inflammation Link: A New Independent Mechanism for Homeostasis
hrp0089p3-p161
Effects of a Brief Physician Delivered Counseling on Childhood Obesity
hrp0089p3-p162
The Prevalence of Obesity in Boys in the Region of the Russian Federation
hrp0089p3-p163
Obesity in Adolescents, is Accompanied by a High Levels of Leptin and a Low Serum Ghr Level in the Blood Plasma. A High Degree of Obesity is Accompanied by a Greater Higher Leptin Level and Decrease in the Ghr Level. These Changes are More Significant Registered in Abdominal Ob
hrp0089p3-p164
Hidden Hunger in Overweight/obese Indian Adolescents
hrp0089p3-p165
Assessment of Obesity in Children with Achondroplasia and Hypochondroplasia
hrp0089p3-p166
Correlation of Lipoprotein(a) Levels and Family History of Cardiovascular Disease in a Sample of Overweight/obese Children and Adolescents
hrp0089p3-p167
Beneficial Effect of Metformin Treatment in Obese Children and Adolescents
hrp0089p3-p168
Comparison of the Effectiveness of a Battery Powered and Manual Toothbrush in Removal of a Dental Plaque for Good Oral Hygiene in Adolesents with Over-Weight
hrp0089p3-p169
Fetal, Neonatal Endocrinology and Metabolism P1
Cardiac and Vascular Assessments in Small- vs Appropriate-for-Gestational-Age Infants at Ages 1 and 2 Years
hrp0089p1-p135
Bone Maturation as a Predictive Factor of Catch-up Growth During the First Year of Life in Born Small for Gestational Age Infants: A Prospective Study
hrp0089p1-p136
Neonatal Screening Tests in Premature Newborns in Southern Brasil
hrp0089p1-p137
Measurement of Estradiol and Testosterone in Umbilical Cord Blood by Gas Chromatography-Tandem Mass Spectrometry (GC-MS/MS); Comparisons with Radioimmunoassay (RIA)
hrp0089p1-p138
Transient Neonatal Iatrogenic Hypothyroidism due to Iodinated Contrast
hrp0089p1-p139
Sexual Dimorphism of IGF1 and IGF2 Expression in the Neonatal Rat Brain
hrp0089p1-p140
Fetal, Neonatal Endocrinology and Metabolism P2
Clinical characteristics of Congenital Hyperinsulinism Caused by Dominant KCNJ11/ABCC8 Mutations
hrp0089p2-p181
Clinical Characterstics, Genotype-Phenotype Correlations and Follow Up of Patients with Congenital Hyperinsulinaemic Hypoglycaemia; Single Center Experience from a Southeastern City of Turkey
hrp0089p2-p182
Congenital Hyperinsulinism: Management and Outcome in West of Scotland
hrp0089p2-p183
20 Cases of Congenital Hyperinsulinism in Ukraine
hrp0089p2-p184
Nifedipine Therapy in Hyperinsulinaemic Hypoglycaemia Due to Mutations in the PMM2 Gene Improves Fast Tolerance, Stabilises Blood Glucose Profile, and Enables Rationalisation of Treatments for Glycaemic Control and Hypertension: The First Reported Trial in 3 Patients in a Tertiary Centre
hrp0089p2-p185
Potentially Modifiable Predictors of Adverse Neonatal Outcomes in Women with Gestational Diabetes Mellitus (GDM)
hrp0089p2-p186
A Boy with Diazoxide Unresponsive Congenital Hyperinsulinism due to a Homozygous ABCC8 Missense Mutation Previously Reported to be Dominant
hrp0089p2-p187
Diazoxide Unresponsive Congenital Hyperinsulinism due to a Novel ABCC8 Missense Mutation
hrp0089p2-p188
Neonatal Hypoglycaemia: Unchanged Risk of Neurodevelopmental Impairment, But Sex-Specific Decreased Fine Motor Function and Increased Internalizing Behaviour at School Age
hrp0089p2-p189
Atypical Hepatoblastoma and Wilm's Tumour in an Infant with Beckwith-Wiedemann Syndrome and Diazoxide Resistant Congenital Hyperinsulinism
hrp0089p2-p190
Association between Rubenstein-Taybi Syndrome and Hyperinsulinaemic Hypoglycaemia
hrp0089p2-p191
Hyperinsulinemic Hypoglycemia in Congenital Disorder of Glycosylation Type-1a (CDG-1a)
hrp0089p2-p192
A Rare Cause of Hyperinsulinemic Hypoglycemia: Costello Syndrome
hrp0089p2-p193
Molecular Defects Identified by Whole Exome Sequencing in a Chinese Boy with Fructose-1,6-Bisphosphatase Deficiency
hrp0089p2-p194
The Benefit of Universal Neonatal Screening for Hypoglycemia
hrp0089p2-p195
Prematurity of 23 or Less Weeks' Gestation is a Risk for Transient Late-Onset Hyperglycemia in Neonates
hrp0089p2-p196
An unusual cause of neonatal hyperglycemia - case report
hrp0089p2-p197
Neonatal Hypocalcemia Due to Maternal Hypovitaminosis D: A Cohort of Children in a Region of Northern Spain
hrp0089p2-p198
Evaluation of Vitamin D Status and Its Correlation with Gonadal Function in Children at Mini-puberty
hrp0089p2-p199
Systemic Pseudohypoaldosteronism Type 1 Due to 3 Novel Mutations in SCNN1A and SCNN1B Genes; Report of 3 Cases
hrp0089p2-p200
Postnatal Growth of Infants with Neonatal Diabetes: Insulin Pump (CSII) Versus Multiple Daily Injection (MDI) Therapy
hrp0089p2-p201
Serum Vaspin Concentration in Full-term, Appropriate-for-Gestational-Age Newborns: Effect of Early-Onset Infections
hrp0089p2-p202
First Three Years of The Congenital Adrenal Hyperplasia Neonatal Screening Program of the State of Parana, Southern Brazil
hrp0089p2-p203
Assessment of the Stretched Penile Length in Sri Lankan Newborns
hrp0089p2-p204
Auxological Catch Up Growth and Evaluation of Spontaneous Motility in the Term Newborn Small for Gestational Age Employing the Prechtl Assessment of General Movements
hrp0089p2-p205
Fetal, Neonatal Endocrinology and Metabolism P3
A Rare Case of Congenital Hyperinsulinemina with ABCC8 Missense Mutation Presenting with Focal Pancreatic Lesion
hrp0089p3-p170
Comparison of Metabolic Parameters of Children's Blood Depending on the Level of Mother's Glycemia During Pregnancy
hrp0089p3-p171
Forty patients with persistent, non-focal congenital hyperinsulinism: Urgent need for new treatment modalities
hrp0089p3-p172
Outcome of Eight Patients with Congenital Hyperinsulinism (CHI) Studied with 18[F]Dihydroxyphenyl-Alanine Positron Emission Tomography Imaging (18F-DOPA-PET-CT) in Argentina
hrp0089p3-p173
Congenital Hyperinsulinism and Maple Syrup Urine Disease a Challenging Combination
hrp0089p3-p174
Neonatal Diabetes Mellitus in Vietnam National Children Hospital
hrp0089p3-p175
Axillary Temperature Relation to Blood Serum Insulin-like Growth Factor-I in the Not-life-Threatened Newborn: Relevance of Preterm Birth
hrp0089p3-p176
Birth Estimated Brain Weight Relation to Ratios between Insulin-like Growth Factor-II and Insulin-like Growth Factor Binding Protein-3 in the Not-life-threatened Newborn: Relevance
hrp0089p3-p177
Congenital Hyperinsulinism in Children with Beckwith-Wiedemann Syndrome
hrp0089p3-p178
Comparison of the Phenylketonuria Phenotypes in Qazvin Province Before and After Neonatal Screening Until 2017
hrp0089p3-p179
From Hypoglycemia to Hyperglycemia
hrp0089p3-p180
Population Screening of Hypophosphatasia. A Metabolopathy to Consider. National Multicentric Study
hrp0089p3-p181
Dumping Syndrome in a Neonate with Esophagical Atresia Surgery
hrp0089p3-p182
Diagnosis and Treatment of Persistent Hyperkalemia in Newborn Twins - Rare Case Report of Gordon Syndrome
hrp0089p3-p183
Mutation in UCP2 Gene: A Rare Cause of Hyperinsulinemic Hypoglycaemia Syndrome in a Small-for-Gestational Age Newborn
hrp0089p3-p184
Hyperinsulinemic Hypoglycaemia Syndrome in Small-for-Gestational Age Newborns: Clinical Characteristics and Genetic Study
hrp0089p3-p185
Pediatric Insulinoma: A Case Report
hrp0089p3-p186
Mutations in Indian children with Neonatal Diabetes
hrp0089p3-p187
Weight Outcome in Infants with Prolonged Hyperinsulinemic Hypoglycemia Treated with Diazoxide vs Those with Spontaneous Resolution
hrp0089p3-p188
Neonatal Hyper- and Hypoglycaemia; Widening the Clinical Phenotype of Transient Neonatal Diabetes Mellitus due to 6q24 Methylation Defects
hrp0089p3-p189
Clinical and Molecular Genetic Characterization of Two Patients due to Mutations
hrp0089p3-p190
Transient Central Hypothyroidism due to Maternal Graves' Disease
hrp0089p3-p191
GH & IGFs P1
Autosomal Dominant Growth Hormone Deficiency due to a Novel c.178G>A Mutation in the GH1 Gene Causing Instability of the Mutant GH Protein (p.Ala34Thr)
hrp0089p1-p141
Growth Hormone Deficiency due to Whole-Gene Deletion of GHRHR
hrp0089p1-p142
Severe Pre- and Postnatal Growth Retardation in a Child Harboring a Novel Homozygous IGF1 Gene Mutation
hrp0089p1-p143
A New p.(Ile66Serfs*93) IGF2 Variant Is Associated with SRS-like Phenotype
hrp0089p1-p144
Response to Growth Hormone in Patients with Isolated Familial Growth Hormone Deficiency due to RNPC3 Mutations
hrp0089p1-p145
Laron Syndrome Patients have an Abnormal Plasma Amino Acid Pattern
hrp0089p1-p146
Serum IGFBP-2 Concentration in Neonates with Potential Diagnosis of Growth Hormone Deficiency (GHD)
hrp0089p1-p147
GH Treatment Causes an Increase in Klotho Concentration in Children with Growth Hormone Deficiency
hrp0089p1-p148
Assesment of SDF-1 and Ang-1 and Ang-2 in Children with Growth Hormone Deficiency before and after 1- year Therapy with Recombinant Growth Hormone
hrp0089p1-p149
Total Sum of Growth Hormone Values Obtained from Growth Hormone Stimulation Test May be Useful in the Diagnosis of Prepubertal Children with Idiopathic Growth Hormone Deficiency
hrp0089p1-p150
Growth of Premature Infants Born Small by Gestational Age
hrp0089p1-p151
Microalbuminuria and Glomerular Filtration Rate in SGA Born Young Adults
hrp0089p1-p152
Testing the Performance of a Preexisting Growth Prediction Model in a Cohort of Prepubertal Patients Born Small for Gestational Age (SGA) Receiving GH Treatment in PATRO Children
hrp0089p1-p153
Early Onset GH Replacement in GH Deficiency: Is Neonatal Hypoglycemia Important for Long Term Follow-Up?
hrp0089p1-p154
Prevalence of Diabetes among Children Treated with Growth Hormone in Israel
hrp0089p1-p155
The Effect of Growth Hormone Treatment in Children after Hematopoietic Stem Cell Transplantation
hrp0089p1-p156
EasypodTM Connect Observational Study: The Italian Experience
hrp0089p1-p157
Patients and Caregivers Perspectives on a Mobile App that Tracks Adherence and Outcomes in Children with Growth Disorders Treated with Recombinant Human Growth Hormone (r-hGH)
hrp0089p1-p158
GH & IGFs P2
Identification of Three Novel GLI2 Gene Variants Associated with Hypopituitarism
hrp0089p2-p206
Clinical and Preliminary Molecular Description of a Cohort of Patients with Growth Retardation due to Severe Primary IGF1 Deficiency (GROWPATI Study)
hrp0089p2-p207
A Novel, Synonymous, Heterozygous, Splicing Variant Affecting the Intracellular Domain of the Growth Hormone Receptor: Causality for Mild Growth Impairment and IGF-I Deficiency in an Affected Patient?
hrp0089p2-p208
A Novel Mutation of Type I Insulin-like Growth Factor Receptor (IGF1R) Gene in a Severe Short Stature Pedigree Identified by Targeted Next-generation Sequencing (NGS)
hrp0089p2-p209
Severe Short Stature, Growth Hormone (GH) Deficiency, Hypospadias, and Microcephaly: New Insights into the Role of Chromosome 4 Long Arm Duplication
hrp0089p2-p210
Growth Hormone Treatment for Short Stature Associated with TRNT1 Deficiency: A Case Series
hrp0089p2-p211
Case Report: Novel Case of Short Stature and Co-occurrence of SHOX Gene Mutation and Fanconi Anemia
hrp0089p2-p212
Different Genetic Causes of Short Stature in a Family
hrp0089p2-p213
Incidence of Cranial MRI Abnormalities in Patients with Isolated Growth Hormone Deficiency: 20 Years of Results
hrp0089p2-p214
Systematic Prospective Study of Eye Funduscopy Before and After Starting Treatment with Growth Hormone in 290 Patients
hrp0089p2-p215
Incidence and Prevalence of GH Deficiency in the Russian Federation - An Analysis of Two Registries
hrp0089p2-p216
The BSPED National GH Audit: Trends in Prescribing from 2013-2016
hrp0089p2-p217
The Rationale and Design of TransCon GH
hrp0089p2-p218
Baseline Demographics of the TransCon GH Phase 3 heiGHt Trial
hrp0089p2-p219
The ZOMATRIP Study: Four Year Combination Therapy of GH and GnRHa in Girls with a Short Predicted Adult Height During Early Puberty: Adult Height Outcome
hrp0089p2-p220
Growth Hormone Treatment in Children Born Small for Gestational Age (SGA)
hrp0089p2-p221
Height Perception of Children with GH Deficiency: Influencing Factors and Links to Psychosocial Functioning
hrp0089p2-p222
Health Lifestyle and Obesity of Adult Patients with Congenital Isolated Growth Hormone Deficiency Treated in Childhood
hrp0089p2-p223
Factors Influencing Health Related Quality of Life in Children/Adolescents with GH Deficiency
hrp0089p2-p224
Health-Related Quality of Life and Psychosocial Functioning in Young Adults Born SGA after GH/GnRHa Treatment
hrp0089p2-p225
Adherence to Treatment in Growth Hormone Deficient and Small for Gestational Age Patients Naive to EasypodTM in Mexico: Final Results of the EasypodTM Connect Observational Study (ECOS)
hrp0089p2-p226
Growth Pattern and Final Height Outcome in Children with Septo-optic Dysplasia and Isolated Hypopituitarism Treated with rhGH in a Single Centre
hrp0089p2-p227
Reliability of Clonidine Testing for the Diagnosis of Growth Hormone Deficiency in Children and Adolescents
hrp0089p2-p228
Area under the Curve of Growth Hormone, An Additional Tool in Assessing Stimulation Test Results
hrp0089p2-p229
Evaluation of Spontaneous Nocturnal GH Secretion: Noe Versus Two Consecutive Nights
hrp0089p2-p230
Relationship between Growth Velocity and Change of Serum Insulin-Like Growth Factor-1 (IGF-1), Serum IGF Binding Protein-3 (IGFBP-3) Concentrations, and IGFBP-3 Promoter Polymorphism during Gonadotropin-Releasing Hormone Agonist (GnRHa) Treatment
hrp0089p2-p231
The Predictive Role of IGF-1 on Irradiation-Dependent Growth Hormone Deficiency (GHD) in Childhood Cancer Survivors (CCS)
hrp0089p2-p232
Effects of Zinc, Magnesium and Vitamin B6 (ZMA) Supplementation on Serum IGF-I, IGFBP-3 and Testosterone Concentrations in Young Athletes
hrp0089p2-p233
High Protein Nutritional Supplementation Increases Serum IGF-I Concentrations in Short Children with Low IGF-I
hrp0089p2-p234
Hormonal Predictors of Growth Hormone Therapy Effectiveness in Children with Short Stature - Evidence from Neural Prediction Model for Final Height
hrp0089p2-p235
Artificial Neural Networks for Prediction Final Height in Children with growth Hormone Deficiency
hrp0089p2-p236
Predictors of Poor Response to Growth Hormone Therapy in Children with Short Stature - Evidence from Neural Prediction Model for Final Height
hrp0089p2-p237
Growth Hormone Therapy and Its Challenges in GH Deficient Cases in a Multinational Population-a Sneak-Peek
hrp0089p2-p238
GH & IGFs P3
Good Growth Response to Growth Hormone Therapy in Short Children with Normal Growth Hormone Secretion
hrp0089p3-p192
Growth Hormone Deficiency Intwo Children with Williams-Beuren Syndrome: The Long-Term Response to Growth Hormone (GH) Therapy
hrp0089p3-p193
Growth Hormone Treatment: Does Timing Matter?
hrp0089p3-p194
Support for Patients Treated with Growth Hormone to Reach their Growth Potential: Addressing Adherence Barriers through Personalised Behavioural Patient-support Programmes
hrp0089p3-p195
Main Discrepancies between Predicted and Observed Growth Responses with iGRO in Children Treated with GHr in Spain
hrp0089p3-p196
Adherence and Long-term Outcomes of Therapy in Pediatric Subjects in Greece Using Easypod Electromechanical Device for Growth Hormone Treatment: The Phase IV Multicentre Easypod Connect Observational Study (ECOS)
hrp0089p3-p197
Growth Hormone Deficiency in Neurofibromatosis: Report of Four Cases
hrp0089p3-p198
Extremely Low Body Mass Index Negatively Impact the Response to Growth Hormone Treatment in Children with Growth Hormone Deficiency
hrp0089p3-p199
Small for Gestational Age (SGA) Patients with Premature Treatment Discontinuation: Their Journey in French Real-life Settings
hrp0089p3-p200
Effects on Near-adult Height and Safety of Recombinant Human Growth Hormone in Growth Hormone Deficiency and Turner Syndrome Patients: Results from the LG Growth Study
hrp0089p3-p201
Final Adult Height After Growth Hormone Treatment in Patients with Turner Syndrome
hrp0089p3-p202
Results of Mecasermin Treatment in Pediatric Patients Evaluated for Severe and Partial Primary Deficiency of IGF-1
hrp0089p3-p203
Children Born Small for Gestational Age Treated with Growth Hormone: Evolutionary Aspects
hrp0089p3-p204
Small for Gestational Age (SGA) Patients in Real Life French Clinical Practice: What is the Difference Between Good and Poor Responders to GH Treatment
hrp0089p3-p205
Body Mass Index (BMI) in Patients with Growth Hormone Deficiency (GHD) at Diagnosis, One Year and Two Years After Treatment with Growth Hormone (GH)
hrp0089p3-p206
Erythropoietin and Granulocyte Macrophage Colony Stimulating Factor Levels in Growth Hormone Deficient Children after 1 Year of Growth Hormone Therapy
hrp0089p3-p207
Cost-effectiveness of Growth Hormone Therapy in Children in Russia
hrp0089p3-p208
Vitamin D Status in Children with Isolated Idiopathic GH Deficiency (GHD) in North and Central Greece
hrp0089p3-p209
A Pilot Study for Comparing Efficacy and Safety of the CinnaTropin® to the Reference Recombinant Human GH in Children with Isolated GH Deficiency and Multiple Pituitary Hormone Deficiency
hrp0089p3-p210
Study of the Effectiveness of GH in Children Born Small for Gestational Age in an Area of Northwestern Spain and its Associated Factors
hrp0089p3-p211
Height Velocity and Height Gain in the First Year of GH Treatment: Predictive Factors of Good Statural Response in Small for Gestational Age (SGA) Patients
hrp0089p3-p212
Role of Insulin like Growth Factors on the Growth Parameters in Children with Acquired Hypothyroidism: An Analysis
hrp0089p3-p213
Two Siblings with Short Stature
hrp0089p3-p214
RHGH Replacement Therapy and Side-Effects: A Retrospective Study of 10 Years
hrp0089p3-p215
Efficacy and Safety of Recombinant Human GH in Treating Chinese Children with Idiopathic Short Stature
hrp0089p3-p216
Comparison the Recombinant Human GH (rhGH) Treatment in Children with Idiopathic Short Stature (ISS) and GH Deficiency (GHD)
hrp0089p3-p217
Bone Age Maturation During the Three Years of GH Treatment in Patients with Idiopathic GH Deficiency and Idiopathic Short Stature: Analysis of Data from LG Growth Study
hrp0089p3-p218
Recombinant Growth Hormone Therapy in Prepubertal Children with Idiopathic Short Stature in Korea: A Phase III Randomized Trial
hrp0089p3-p398
Growth & Syndromes P1
Does X-Chromosome Gene Dosage Determine Growth and Phenotypic Features in Turner Syndrome with 45,X/46,XX Mosaicism on Standard Karyotyping? A Cross-Sectional Analysis of the French National Rare Disease Network Database
hrp0089p1-p159
Abstract unavailable
hrp0089p1-p160
Analysis of Osteoblats Precursors in Girls with Turner Syndrome
hrp0089p1-p161
Comparing the Cumulative Dose of Growth Hormone Therapy Using Body Weight-Based Dosing Versus Body Surface Area-Based Dosing in Children with Turner Syndrome - Data from the ANSWER Study
hrp0089p1-p162
The Association between Growth Hormone Dose and Short-Term Height Outcomes in a Large Cohort of Paediatric Patients with Turner Syndrome: Real-World Data from the NordiNet® International Outcome Study (IOS) and ANSWER Program
hrp0089p1-p163
Changing Patterns of Growth in Prader-Willi Syndrome
hrp0089p1-p164
Sleep-Disordered Breathing in Children with Prader-Willi Syndrome in relation to Growth Hormone Therapy Onset
hrp0089p1-p165
Safety and Effectiveness of Growth Hormone Treatment in Patients with Prader-Willi Syndrome under 2 Years of Age in a Reference Hospital
hrp0089p1-p166
Improved Mental and Motor Development During 3 Years of GH Treatment in Very Young Children with Prader-Willi Syndrome
hrp0089p1-p167
GH Response to GHRH and Arginine in Previously GH-Treated Young Adults with Prader-Willi Syndrome
hrp0089p1-p168
A Novel Type of Pubertal Height, Weight, and BMI Reference, Aligned for Onset of Puberty
hrp0089p1-p169
Evaluating Cut-offs for Automatic Growth Screening in Swedish Children - Using the Finnish Growth Monitoring Algorithm
hrp0089p1-p170
Prospective Study of Growth in Swedish Children Treated with Modified Ketogenic Diet
hrp0089p1-p171
Early Gut Microbiota and childhood Growth
hrp0089p1-p172
Clinical and Radiological Manifestations in a Large Swedish Family with a Pathogenic Heterozygous ACAN Variant
hrp0089p1-p173
Identification of ADAMTS6 as a Novel Candidate Gene for Idiopathic Short Stature with Advanced Bone Maturation
hrp0089p1-p174
Dual Function of the Retinoic Acid Catabolizing Enzyme CYP26C1 - Underlying Idiopathic Short Stature and Modifying Disease Severity in SHOX Deficiency
hrp0089p1-p175
Growth Plate Disorders are the Main Cause of Severe Familiar Short Stature in Children Classified and Treated with Growth Hormone as SGA or GHD
hrp0089p1-p176
Genetic Investigation of Children with Syndromic Prenatal Onset Short Stature
hrp0089p1-p177
Identification of Three Novel Mutations in 10 Pediatric Patients with Unexplained Syndromic Short Stature Identified by Targeted Exome Sequencing in Korea
hrp0089p1-p178
Beckwith Wiedemann Syndrome: First International Consensus Regarding Diagnosis and Clinical Management
hrp0089p1-p179
Silver Russell and Beckwith-Wiedemann Syndromes: Mosaic Distribution of Epigenetic Anomalies
hrp0089p1-p180
Long Term Effects of Childhood Growth Hormone Treatment on Height and Body Mass Index in Adolescents and Adults with Silver-Russell Syndrome
hrp0089p1-p181
Year-one Effectiveness and Overall Safety of NutropinAq® for Growth Hormone Deficiency (GHD) and Other Paediatric Growth Disorders: Completion of the International Cooperative Growth Study (iNCGS) European Registry
hrp0089p1-p182
Carriers of IGF1-receptor Mutations As A Subgroup of SGA Patients: A Comprehensive Retrospective Comparison of Response to rhGH Treatment and Health Profile
hrp0089p1-p183
Characteristics, Effectiveness and Safety Data for Patients with Growth Failure Treated with Recombinant IGF-I (rhIGF-I) and Achieving Adult or Near-adult Height (AH): Results from the European Increlex® Growth Forum Database (EU-IGFD) Registry
hrp0089p1-p184
Growth Outcome in Girls with Idiopathic Central Precocious Puberty Treated with Gonadotropin-releasing Hormone Agonist
hrp0089p1-p185
Maternal Uniparental Disomy for Chromosome 20: Physical and Endocrinological Characteristics of Six Patients
hrp0089p1-p186
A Novel Deadly Variant in the TP53 Gene Causing Li-Fraumeni Syndrome. The Importance of Clinical Awareness and the Contribution of Molecular Diagnosis in Active Prevention Within Families with Multiple Tumor Incidents at a Young Age
hrp0089p1-p187
Mutations in SHOX, GHR and IGFALS Genes Among Indian Children with 'Idiopathic Short Stature'
hrp0089p1-p188
Growth & Syndromes P2
Heart and Aorta Anomalies in Turner Syndrome and Relation with Karyotype
hrp0089p2-p239
The Validation of an Automated Bone Age Assessment in Girls with Turner Syndrome - A Pilot Study
hrp0089p2-p240
Turner Syndrome and Autoimmune Thyroid Disease: Pecularities of Evolution in 93 Turner Syndrome Patients
hrp0089p2-p241
Unusual Clinical Manifestations in Turner Syndrome
hrp0089p2-p242
Effect of Combined GH and Estrogen Treatment on the Lipid Profile and Systolic Function of the Left Ventricle in Girls with Turner Syndrome (TS)
hrp0089p2-p243
Familial Turner Syndrome: Case Report
hrp0089p2-p244
Clinical Review of Seven Patients Affected with 49,XXXXY Syndrome
hrp0089p2-p245
Poor Weight Gain in Prader-Willi Syndrome - Not Always Over-restriction Consider Coeliac Disease
hrp0089p2-p246
GH Unmasked Laryngomalacia and worsened Obstructive Sleep Apnea in Infants with Prader-Willi Syndrome
hrp0089p2-p247
How Frequent Are Growth Charts Used in Paediatric Clinics? An Audit of Growth Chart Use in a District General Hospital in Scotland
hrp0089p2-p248
GrowInform - A Campaign for Early Diagnosis and Treatment of Growth Disorders
hrp0089p2-p249
Growth and Body Composition of Term Healthy Indian Infants from Birth to 2 Years of Age
hrp0089p2-p250
Growth, Body Composition and Metabolic Parameters during Childhood in a Cohort of Children Born with a Small for Gestational Age
hrp0089p2-p251
Final Results of NordiNet® International Outcome Study: Key Outcomes in Paediatric Patients
hrp0089p2-p252
Influence of Puberty on Adult Height of SGA Children Treated with GH
hrp0089p2-p253
Burden and Impacts of Daily Recombinant Human Growth Hormone (r-hGH) Injections in Growth Hormone Deficient (GHD) Paediatric Patients
hrp0089p2-p254
Clinical and Cost-Effectiveness of GH Treatment for Children in Wales
hrp0089p2-p255
Bone Mineral Density and Body Composition of Young Adults Who Were Born Small for Gestational Age and Treated with Growth Hormone, after Treatment Completion
hrp0089p2-p256
Clinical Effectiveness and Cost-Effectiveness of Somatropin Treatment for Short Children in Egypt: Analysis of 1-Year Data
hrp0089p2-p257
Clinical and Molecular Analyses of 24 Patients with Beckwith-Wiedemann SYNDROME
hrp0089p2-p258
Unusual Case of Combination of Beckwith-Wiedemann Syndrome and SHOX Gene Deficiency
hrp0089p2-p259
An Irish Regional Study of Paediatric Growth Hormone Deficiency (CO-GHD): Classification of Causes and Factors Associated with Persistent GHD at Transition
hrp0089p2-p260
Two Different Variants of Short Stature Homeobox-Containing Gene (SHOX) Mutation in the Same Family
hrp0089p2-p261
Identification of a Novel Heterozygous ACAN Mutation in a Patient with Non-Syndromic Short Stature
hrp0089p2-p262
Genetic Investigation of SHORT Stature: A Case Report of Complex Constitutive Rearrangement Involving Chromosome 15
hrp0089p2-p263
Targeted/Exome Sequencing Identified Mutations in 55 Chinese Children Diagnosed with Noonan Syndrome and a Autosomal Recessive form Associated with LZTR1 Variants
hrp0089p2-p264
A Novel Heterozygous Missense Variant in the LZTR1 Gene as a Cause of Noonan Syndrome
hrp0089p2-p265
A Novel FGFR1 Mutation in Kallmann Syndrome with Growth Hormone Deficiency
hrp0089p2-p266
Clinical and Molecular Characterization of Eight Chinese Children with Cornelia de Lange Syndrome Using Targeted Next Generation Sequencing
hrp0089p2-p267
A New Mutation in IHH Gene Causing Severe Short Stature
hrp0089p2-p268
Case Report: Ellis Van Creveld Syndrome With a Novel Mutation
hrp0089p2-p269
A Homozygous Pathogenic Variant in the TRHR Gene in a Boy Who Presented With Severe Familial Short Stature and Central Hypothyroidism
hrp0089p2-p270
Unexpected Growth Patterns in Branchio-Oto-Renal Syndrome
hrp0089p2-p271
Mild Autistic Spectrum Disorder in a 33 Year-old Male Japanese Patient with Temple Syndrome
hrp0089p2-p272
Seventeen-year Observation in a Japanese Female Case of Tatton-Brown-Rahman Syndrome: An Overgrowth Syndrome with Intellectual Disability
hrp0089p2-p273
KBG Syndrome: Our Experience and Unreported Clinical Features
hrp0089p2-p274
Growth of Infants Born by Intracytoplasmic Sperm Injection (ICSI) Technique
hrp0089p2-p275
Earlier Mother's Age at Menarche is a Risk Factor of Daughter's Early Menarche and Short Stature in Young Korean Female: Epidemiologic Study
hrp0089p2-p276
Pulling the Brakes - 'Catch Down Growth': A Phenomenon for Achieving Mid-parental Height Centile After Acquired, All-cause, Brain Injury
hrp0089p2-p277
Effects of Inhaled Corticosteroids and Montelukast on Growth and BMI in Children with Asthma
hrp0089p2-p278
Abstract unavailable
hrp0089p2-p279
Skeletal Disproportion and Growth Impairment in Glucocorticoid Treated Boys with Duchenne Muscular Dystrophy
hrp0089p2-p280
A Novel Mutation in the SLC2A2 Gene in a 19-Year-Old Female with Diabetes Mellitus and Renal Tubular Acidosis: A Therapeutic Conundrum
hrp0089p2-p281
Vesico-Ureteral Reflux and Effect on Growth Indices
hrp0089p2-p282
A Novel in Frame Deletion Mutation in Exon11 in BTK Gene to X-linked Agammaglobulinemia: Case Report and Function Analysis
hrp0089p2-p283
Growth & Syndromes P3
Is Growth Hormone Deficiency a Contributor to Short Stature in Cutis Laxa Syndrome?
hrp0089p3-p219
Effect of Sickle Cell Disease on Growth and Puberty
hrp0089p3-p220
Two Siblings with Alstrom Syndrome
hrp0089p3-p221
Development of an Online Learn-pro Module to Support Health Care Professionals Knowledge about Growth and Puberty
hrp0089p3-p222
Coeliac Disease in Turner Syndrome More Frequent Than Expected
hrp0089p3-p223
A 14-Year-Old Boy with Simpson-Golabi-Behmel Syndrome - Case Report
hrp0089p3-p224
Central Precocious Puberty in a Girl with Silver Russell Syndrome
hrp0089p3-p225
Etiologies of Short Stature in Pedaitric Endocrine Clinic in Northwest Region (Trakya) of Turkey
hrp0089p3-p226
Auditing Presentation, Investigations and Management of Turner's Syndrome
hrp0089p3-p227
Children Born Small for Gestational Age: Catch-up Growth During the First Four Years of Life
hrp0089p3-p228
A Novel Heterozygous Pathogenic Variant in PORCN Gene Causing Focal Dermal Hypoplasia with Short Stature: Case Report and Literature Review
hrp0089p3-p229
Endocrinological Evaluation of Girls with Turner Syndrome Attending Alexandria University Children's Hospital
hrp0089p3-p230
A Long Follow-up in a Young Patient with Atypical Progeroid Syndrome
hrp0089p3-p231
GH Treatment in Kabuki Syndrome: A Case Report
hrp0089p3-p232
GH Treatment in Oto-Spondylo-Megaepiphyseal Dysplasia: A Case Report
hrp0089p3-p233
Hepatic Glycogen Synthasedeficiency Associated with Growth Hormone Deficiency: A Case Report
hrp0089p3-p234
Analysis of Genetic Mutations in a Chinese Patient Affected with Noonan Syndrome
hrp0089p3-p235
A Novel Homozygous Mutation in ERCC8 Cause Cockayne Syndrome a in a Chinese Family
hrp0089p3-p236
Growth Hormon Deficiency in Identical Twins with Gitelman Syndrome due to Compound Heterozygous Mutation (p.R80fs*35/p.K957X) of the SLC12A3 Gene and the Evaluation of the Response to Growth Hormone Replacement Therapy
hrp0089p3-p237
Hypothyroidism and Growth Hormone (GH) Deficiency, a Spotlight on De Novo Chromosomal 20p11.2 Deletion
hrp0089p3-p238
Pharmacoeconomic and Adherence Analysis in Growth Hormone According to Galenic Presentation: In Vivo Study vs In Vitro
hrp0089p3-p239
The Expression of Cytokines in SGA Children Throughout Lactation Allows to Characterize Early the Type of Cath-up
hrp0089p3-p240
Small Stature: A Singular Difference for Accessing to Job
hrp0089p3-p241
A Case of Hutchinson-Gilford Progeria Syndrome (HGPS) due to a Pathogenic LMNA Variant c.433G>A (p.Glu145Lys): Growth Hormone Administration Failed to Improve Growth and Long-term Outcome
hrp0089p3-p242
Increased Serum Activity of Liver Aminotransferases in Young Patients with Turner Syndrome
hrp0089p3-p243
Terner Syndrome: Epidemiological Study in Uzbekistan
hrp0089p3-p244
Shox Haploinsufficiency in Short and Not Short Children: A Sigle Italian Cetre Data
hrp0089p3-p245
Microduplication of 3p25.3 and 4p23 Regions in a Patient with Multiple Congenital Anomalies, Congenital Hypothyroidism and Adrenogenital Syndrome
hrp0089p3-p246
A Rare Chromosomal Disorder, Trisomy 4p
hrp0089p3-p247
Prediction of Response to Growth Hormone Treatment in Korean Girls with Turner Syndrome
hrp0089p3-p248
A Rare Case of Turner Syndrome with the Presence of the Y Chromosome Genetic Material
hrp0089p3-p249
Prader-Willi Patient with Rectal Bleeding - Experience in Center for Rare Endocrine Disordesrs in Varna, Bulagria
hrp0089p3-p250
Mosaicism 47XXX/45X0, a Case Report
hrp0089p3-p251
Factors Influencing the Selection of Injection Areas During Self-therapy for Growth Hormone Therapy Among Patients 10-15 Years Old
hrp0089p3-p252
Tall Stature: A Diagnosis is Sometimes Difficult
hrp0089p3-p253
Woodhouse-Sakati Syndrome: Clinical and Molecular Study on a Qatari Family with C2orf37 Gene Mutation
hrp0089p3-p254
Factors Affecting Height Velocity in Normal Prepubertal Children
hrp0089p3-p255
Low Dose Growth Hormone using IGF1 Dose Titration is Associated with Sustained Optimal Growth in a Child with Both Turner and Down Syndrome
hrp0089p3-p256
Growth Response in Noonan Syndrome in Indian Children
hrp0089p3-p257
Late Referral of Siblings with Combined Pituitary Hormone Deficiency (PROP1)
hrp0089p3-p258
17p13.1 Microduplication Syndrome in a Child with Familial Short Stature and GH Deficiency: A Short Case Report
hrp0089p3-p259
Prader Willi Syndrome: Clinical Profile
hrp0089p3-p260
Leri-Weill Syndrome Phenotype with Atypical Cytogenetic Finding
hrp0089p3-p261
Deletion of 12q12 Increases the Risk of Growth Retardation and Intellectual Disability
hrp0089p3-p262
A Patient with Turner Syndrome (45X/46XX) and Congenital Adrenal Hyperplasia
hrp0089p3-p263
Congenital Tufting Enteropathy Caused by Mutation of EPCAM Gene: A Case Report and Review of Literature
hrp0089p3-p264
Is Using a Specific Growth Charts a Chance to be More Precise in Evaluation the Growth of the Children and Adolescence with Down Syndrome? Comparison of the Down's Syndrome Growth Charts with the Growth Charts for Polish Population
hrp0089p3-p401
Two Siblings with Prader-Willi Syndrome Caused by Microdeletion Derived from the Paternal Grandmother
hrp0089p3-p406
Novel Mutation of CHD7 in a Chinese Boy with Kallmann Syndrome
hrp0089p3-p412
Conversion of Hypothyroidism to Hyperthyroidism in Children
hrp0089p3-p413
Case Report: Novel ACAN Mutation in a SGA Short Stature without Accelerated Skeletal Maturation
hrp0089p3-p415
Multisystem Endocrine Disorders P1
Clinical Features and Assessment of the Pathway-Care Proposed by ISPED-Gsa Study Group in an Pediatric Italian Cohort with Pseudohypoparathyroidism
hrp0089p1-p189
Overview of Leading Causes of Death among French Patients with Prader-Willi Syndrome, 2004-2014
hrp0089p1-p190
SGPL1 Missense Mutation in an Infant with Primary Adrenal Insufficiency (PAI), Congenital Nephrotic Syndrome, Primary Hypothyroidism and Gonadal Failure
hrp0089p1-p191
Final Adult Height, Insulin-like Growth Factor 1 (IGF-I) Concentration in Adolescents and Young Adults with [beta]-Thalassemia Major (BTM) with and Without Growth Hormone Deficiency
hrp0089p1-p192
McCune-Albright-Syndrome: Clinical and Genetic Study in a Large Cohort of Pediatric Patients
hrp0089p1-p193
Multisystem Endocrine Disorders P2
Endocrine and Metabolic Complications in Children and Adolescents with Sickle Cell Disease: An Italian Cohort Study
hrp0089p2-p284
Bone Marrow Failure in McCune Albright Syndrome
hrp0089p2-p285
Final Adult Height, Insulin-Like Growth Factor 1 (IGF-I) Concentration and Endocrine Complications in Adolescents and Young Adults with [beta]-Thalassemia Major (BTM) Who Received Oral Iron Chelation (OIC) in Comparison with Those Who Did Not Use OIC
hrp0089p2-p286
Endocrine Challenges in Patients with Thalassemia
hrp0089p2-p287
Can Oral Iron Chelation Therapies Reduce Endocrine Complications in [beta]-Thalassemia Major Patients?
hrp0089p2-p288
Statural Growth and Endocrinopathies in Relation to Liver Iron Content (LIC) and Insulin-Like Growth Factor 1 (IGF-I) Concentration in Adolescents with Beta Thalassemia Major (BTM) and Sickle Cell Disease (SCD)
hrp0089p2-p289
Successful Treatment of Severe Atopic Dermatitis with Calcitriol and Paricalcitol in an 8-Year Old Girl
hrp0089p2-p290
Hypoglycemia in Adolescence as the Presenting Sign of Familial MEN1
hrp0089p2-p291
Aldosterone, Renin, Sodium and Potassium Excretion in Normotensive Prepubertal Children
hrp0089p2-p292
What is the Impact of a Structured Healthcare Pathway Dedicated to Patients in Transition on Their Long-term Follow-up?
hrp0089p2-p293
British Society for Paediatric Endocrinology and Diabetes Peer Review of Specialised Paediatric Endocrinology Services in the UK - Evaluation of the Process
hrp0089p2-p294
Paediatric Endocrinology Mapping and Services in Nigeria: A Decade After
hrp0089p2-p295
The Impact of Military Conflict in the East of Ukraine on the Physical Development of Children and Adolescents
hrp0089p2-p296
Polycystic Ovary Syndrome Metabolic Syndrome Predisposition in Puberty
hrp0089p2-p297
Fanconi-Bickel Syndrome in Sudanese Children, Case Series
hrp0089p2-p298
The N309K Pro-Protein Convertase Type 1 (PCSK1) Gene Mutation Causes Lack of Spontaneous Puberty and Primary Amenorrhea
hrp0089p2-p299
Somatostatin Experiment in Prohormone Convertase Deficiency
hrp0089p2-p300
Multisystem Endocrine Disorders P3
Insulinoma as Initial Presentation of Multiple Endocrine Neoplasia Type 1
hrp0089p3-p265
Assessment of Ovarian Reserve in Young Women with Hashimoto Disease - The Pilot Study
hrp0089p3-p266
Unusual Clinical Presentation of Autoimmune Polyendocrinopathy Type 1
hrp0089p3-p267
Glycemic Abnormalities and Normal Thyroid Function in Adolescent Survivors of Childhood Acute Lymphocytic Leukemia Who Required Repeated Packed Red Cell Transfusion During Treatment
hrp0089p3-p268
Graves' Disease in Children with T1DM: A Report of Three Cases
hrp0089p3-p269
Case Report: Neonatal McCune-Albright Syndrome with Juvenile Ovarian Granulosa Cell Tumor in a 4 Months Old Girl
hrp0089p3-p270
Polyostotic Fibrous Dysplasia of McCune Albright Syndrome Responding to Intravenous Zoledronate Therapy
hrp0089p3-p271
Two Cases of Costello Syndrome and Literatures Review
hrp0089p3-p272
Endocrine Complications in Beta-Thalassaemia Major Children
hrp0089p3-p273
The Case of Combination of Multinodular Goiter and Sertoli-Leydig Cell Ovarian Tumor due to Mutation in DICER1 Gene
hrp0089p3-p274
Unusual Case of Autoimmune Polyglandular Syndrome
hrp0089p3-p275
Autoimmunepolyendocrinopathy-Candidiasis-Ectodermal Dystrophy: A Case Report
hrp0089p3-p276
Wolman Disease: Long-Term Endocrine and Metabolic Comorbidities
hrp0089p3-p277
Pallister Hall Syndrome: with a Varied Spectrum of Endocrine Disorders
hrp0089p3-p278
Near Electromagnetic Fields - Induced Syndrome: Unsuspected and Newly Recognised
hrp0089p3-p279
Polycystic Ovary Syndrome Gene/Gene Products Interaction Network
hrp0089p3-p280
Basal Metabolic Rate as Moderator of Inflammation in PCOS
hrp0089p3-p281
Insight of Differential Diagnosis of DAX-1 from Two Patients with Elevated Testosterone in Early Infancy
hrp0089p3-p282
Rapid Onset and Progression of Chronic Kidney Disease in a Child with Autoimmune Polyglandular Syndrome Type 1
hrp0089p3-p283
Clinical Characteristics and Outcome of Patients with Beta-Ketothiolase Deficiency in China
hrp0089p3-p402
Lessons from Wolfram Syndrome: Initiation of DDAVP Therapy Causes Renal Salt Wasting due to Elevated ANP Levels, Rescued by Fludrocortisone Treatment
hrp0089p3-p405
A Novel Detrimental Homozygous Mutation of WFS1 Gene in Two Sisters from Non-consanguineous Parents with Untreated Diabetes Insipidus
hrp0089p3-p410
General Public' Attitudes Towards the Use and Storage of NBS Blood Samples for Research in China
hrp0089p3-p411
Pituitary, Neuroendocrinology and Puberty P1
A 7-Year Update Report of a National, Interdisciplinary Endeavour to Improve Outcomes for Children and Young People Under 19 Years of Age with Hypothalamic Pituitary Axis Tumours (HPAT) Using Multi-site Video Conferencing
hrp0089p1-p194
Long Term Reversibility of Presumed ACTH Deficiency (ACTHd) in Children and Young People (CYP) with Intracranial Germ Cell Tumours (IGCT)
hrp0089p1-p195
Endocrine Follow-up of Children with a History of Brain Tumour: Data from Our Large Cohort at Necker University Hospital, Paris, 2010-2015
hrp0089p1-p196
A Single Centre Experience of Managing a Series of Childhood Macro/Giant-Prolactinoma
hrp0089p1-p197
A National UK Guideline for Managing Pituitary Adenomas in Children and Young People Under 19 Years Developed According to the AGREE II Framework
hrp0089p1-p198
Growth Hormone Deficiency and Cryptorchidism in a Family with Xq26.3 Duplication and Position Effect on SOX3
hrp0089p1-p199
PROKR2 Mutations in Patients with Growth Hormone Deficiency and Multiple Pituitary Hormone Deficiency
hrp0089p1-p200
Anastrozole is Safe as Monotherapy in Early Maturing Girls with Compromised Growth, Further Improving Gain in Predicted Adult Height by the Initial Combination Therapy of an LHRH Analogue and an Aromatase Inhibitor: Results from the 'Gail' Study ISRCTN11469487
hrp0089p1-p201
Long-acting Octeotride Treatment in Children with Neurofibromatosis Type 1 - Optic Pathway Tumors and Growth Hormone Excess
hrp0089p1-p202
Serum Concentrations of the Endocrine Disruptors-organochlorine Pesticides (OCPs) in Greek Children with Neurodevelopmental Disorders
hrp0089p1-p203
Whole-exome Sequencing Identifies Novel Pathogenic Variants in Korean Families with Central Precocious Puberty
hrp0089p1-p204
A Paternally Inherited Familial Precocious Puberty Caused by a Novel MKRN3 Frameshift Variant
hrp0089p1-p205
MKRN3 Levels in Girls with Central Precocious Puberty During GnRHa Treatment: A Longitudinal Study
hrp0089p1-p206
Urinary Gonadotropins as a Useful Non-invasive Marker of Central Precocious Puberty
hrp0089p1-p207
Testicular Development and Puberty in Boys with Duchenne Muscular Dystrophy: Results From the ScOT-DMD Study
hrp0089p1-p208
Exposure to BPA and Phthalates and Timing of Puberty in Girls
hrp0089p1-p209
Hypothalamic-pituitary-testicular Axis Response to Sub-maximal Aerobic Exercise, in Pre- and Early- Pubertal Normal Weight and Obese Boys
hrp0089p1-p210
Effect of Pubertal Blockade and Cross-sex Hormone Treatment on the Growth Spurt in Young Transgender Adolescents: A First Report
hrp0089p1-p211
Real-World Safety Data in a Cohort of Children with Noonan Syndrome Treated with GH: Final Results from NordiNet International Outcome Study (IOS) and ANSWER Program
hrp0089p1-p212
Pituitary, Neuroendocrinology and Puberty P2
Efficacy and Safety of Triptorelin 3-Month Formulationin Patients with Central Precocious Puberty and BMI Evaluation.
hrp0089p2-p301
Triptorelin Test in Idagnosing Central Precocious Puberty
hrp0089p2-p302
Foot Length Growth is a Novel Marker of Early Puberty
hrp0089p2-p303
Ultrasound-Based Measurements of Testicular Volume in 6-16 Year Old Boys: Intra- and Inter-Observer Agreement and Comparison with Prader Orchidometry
hrp0089p2-p304
Abstract unavailable
hrp0089p2-p305
Longitudinal Follow-up to Near Final Height of Auxological Changes in Girls with Idiopathic Central Precocious Puberty Treated with Gonadotropin-Releasing Hormone Analog and Grouped by Pretreatment BMI level
hrp0089p2-p306
The Effect of GnRH-Analogue Therapy on the Quality of Life of Patients with Central Precocious Puberty and Their Families
hrp0089p2-p307
A Novel Inactivating Compound Heterozygous Mutation in KISS1R/GPR54: Cases of Three Siblings
hrp0089p2-p308
MKRN3 Gene Mutations in a Cohort of Patients with Central Precocious Puberty
hrp0089p2-p309
Can Basal Levels of Luteinizing Hormone (LH) Replace the GnRH Test in the Diagnosis of Precocious Puberty in Girls?
hrp0089p2-p310
Incidence of Delayed Puberty in Adolescents. A Population-Based Study in a County in Central Sweden
hrp0089p2-p311
Ultrasound Assessment of Pubertal Breast Development: Intra- and Inter-Observer Agreement
hrp0089p2-p312
Neuroendocrine Consequences of Hypothalamic Hamartoma and their Imaging (MRI) and Surgery Correlates
hrp0089p2-p313
The Start Predictors of Puberty in Boys with Constitutional Delay of Puberty
hrp0089p2-p314
Research on the Relationship between Secular Trends of Pubertal Development and Obesity in Child and Adolescent
hrp0089p2-p315
Gonadotropin Levels and Frequency of Testosterone Supplementation in Adolescents with Klinefelter Syndrome
hrp0089p2-p316
The Effect of Letrozole on the Reproductive Function and Linear Growth in the Early and Mid Puberty Boys
hrp0089p2-p317
SOX3 Gene Duplication Associated with Midline CNS Malformations, Hypopituitarism and Neurodevelopmental Abnormalities: 5 Unrelated Cases
hrp0089p2-p318
An 18 Month Old Boy with Hypoglycemic Convulsion and Obesity Due to POMC Deficiency
hrp0089p2-p319
Pituitary Stalk Interruption Syndrome (PSIS) is Not a Rare Cause of the Congenital Hypopituitarism
hrp0089p2-p320
Pallister Hall Syndrome: An Unusual Case of Central Precocious Puberty, Prolonged Vaginal Bleeding, Gelastic Seizures and Polysyndactyly in a 3 Month Old Infant
hrp0089p2-p321
Primary Empty Sella Syndrome and Clnical Endocrine Polymorphisms in Children: a Report of 15 Cases
hrp0089p2-p322
Growth Hormone Deficiency (GHD) in a Patient with Persistence of the Craniopharyngeal Canal with Cephalocele
hrp0089p2-p323
Endocrine-Metabolic Characterization of Pediatric Patients with Craniopharyngioma: A Single-centre Cohort study
hrp0089p2-p324
Growth Hormone (GH) Secreting Pituitary Adenomas in Paediatric Practice: 5 Cases Over 20 Years in a Single Tertiary NeuroEndocrine Centre
hrp0089p2-p325
Pituitary Adenomas in Children and Adolescents: A Retrospective Single-Centre Analysis
hrp0089p2-p326
Changes of Body Composition of Male Adolescents with GH Deficiency are Diagnostic During Transition
hrp0089p2-p327
AMH and Inhibin B Level in Girls with Central Precocious Puberty
hrp0089p2-p328
Gender-Related Differences in Etiological Distribution of Organic Causes of Central Precocious Puberty
hrp0089p2-p329
Final Adult Height in Girls with Idiopathic Central Precocious Puberty Treated with Monthly Leuprorelin Acetate VS Triptorelin Acetate
hrp0089p2-p330
The Impact of Central Precious Puberty on Health-relatedqualityoflifeand Social, Emotive and Behavioral Competences Among Children Treated with GnRHa
hrp0089p2-p331
Basal and GnRH Analog-stimulated Peak LH Levels for Diagnosing Girls with Early Phase of Central Precocious Puberty
hrp0089p2-p332
Determination of Urinary Metabolic Profiles of Children with Central and Peripheral Precocious Puberty
hrp0089p2-p333
Hypertension During GNRH Analogues Therapy in a 10-year-old Girl
hrp0089p2-p334
The Effect of Polychlorinobiphenyls on Premature Puberty in Girls
hrp0089p2-p335
A Novel Mutation in 5'; Untranslation Region of Makorin Ring Finger 3 Gene Associated with the Familial Precocious Puberty
hrp0089p2-p336
A Case of Testotoxicosis Due to a Constitutive Mutation of the LH Receptor Initially Presented as a Central Precocious Puberty at 3 Years Old
hrp0089p2-p337
Pituitary, Neuroendocrinology and Puberty P3
Infant with Osteogenesis Imperfecta and Panhypopituitarism: A Case Report
hrp0089p3-p284
Panhypopituitarism with Tall Stature Diagnosed in a 20 Years Old Boy
hrp0089p3-p285
Post-Traumatic Hypopituitarism Caused by Pituitary Stalk Transection
hrp0089p3-p286
Invasive Macroprolactinoma with Cabergoline Induced Cerebrospinal Fluid Rhinorrhoea in Childhood
hrp0089p3-p287
Bilateral Optic Nerve Hypoplasia Revealing Septo Optic Dysplasia or De Morsier Syndrome: A Case Report
hrp0089p3-p288
Investigating Malnutrition Among Children Diagnosed with Neuroendocrine Tumors Receiving Chemotherapy in a Tertiary Care Hospital of Pakistan
hrp0089p3-p289
An Interesting Etiology in Childhood Central Diabetes Insipidus HIBERNOMA
hrp0089p3-p290
Neonatal Panhypopituitarism with Hypoglycemia, Edema, Inspiratory Stridor and Cholestasis
hrp0089p3-p291
MRI Changes in Time after Cranial Irradiation, and their Relation with Pituitary Function in Survivors of Childhood Medulloblastoma
hrp0089p3-p292
Two Identical Twins … But not in Everything. A Difficult Diagnosis
hrp0089p3-p293
Growth Hormone Deficit Associated to Complex Arteriovenous Malformation - Case Report
hrp0089p3-p294
Does Acquired Hypothyroidism Lead to Precocious Puberty?
hrp0089p3-p295
Analysis of Influencing Factors on Bone Maturation in Girls with Central Precocious Puberty (CPP)
hrp0089p3-p296
Is Premature Adrenarch Associated with Precocıous Puberty via Kisspeptin?
hrp0089p3-p297
Distinct Presentations of McCune Albright Syndrome, Report of Two Cases
hrp0089p3-p298
A Case of Atypical McCune-Albright Syndrome with Vaginal Bleeding
hrp0089p3-p299
Evaluation of Cases with Pubertal Gynecomastia
hrp0089p3-p300
A Case of Central Diabetes Insipidus Developed 4 Years after the Non-CNS-Risk Unifocal Bone Lesion of Langerhans Cell Histiocytosis
hrp0089p3-p301
Effect of Triptoreline in Patients with Central Precocious Puberty at Children's Hospital 1, Ho Chi Minh City, Vietnam
hrp0089p3-p302
Morning Basal Luteinizing Hormone, A Good Screening Tool for Diagnosing Central Precocious Puberty
hrp0089p3-p303
A 2-Year-Old Boy with Epiphysis Tumor and Precocious Puberty
hrp0089p3-p304
Central Precocious Puberty as a Result of Hypotalamus Hamartoma
hrp0089p3-p305
Precocious Puberty as a Result of Ectopic Hormone-Producing Tumor
hrp0089p3-p306
Premature Adrenarche and Pseudohypoparathyroidism - Mechanistically Linked or Coincidence?
hrp0089p3-p307
Efficacy of Ziyin Xiehuo Granules and Zishen Qinggan Granules in girls with Partial Precocious Puberty: A Multicenter, Randomized, Single-Blinded, Controlled Trial
hrp0089p3-p308
GLP-1 Receptor Agonist in a Patient with Craniopharyngioma-Related Obesity
hrp0089p3-p309
Poland's Syndrome and Hypogonadotropic Hypogonadism
hrp0089p3-p310
Congenital Hypopituitarism Associated with Complex Cranio-Vertebral Junction Anomalies
hrp0089p3-p311
Premature Thelarche Followed by Acute Lymphoblastic Leukemia in a 1.5 Year Old Girl
hrp0089p3-p312
Two Cases of Non-syndromic Congenital Unilateral Hypoplasia in One Family
hrp0089p3-p313
Klinefelter Syndrome with Ambiguous Genitalia in a Child
hrp0089p3-p314
The Change in Growth's Velocity in Patients with Premature Puberty Receiving Treatment with Analogues of Lyuliberin
hrp0089p3-p315
The Efficacy of Treatment in Vietnamese Children with Central Precocious Puberty
hrp0089p3-p316
The Characteristics of Central Precocious Puberty at Children's Hospital 2 in Vietnam
hrp0089p3-p317
SIG (Special Interest Group)-ENDOPED/RUTE (Brazil): Seven Years Integrating Pediatric Endocrinology Centers throughout the Country
hrp0089p3-p318
The Relationship Between Prolactin and Development of Puberty in Girls with Early Breast Development
hrp0089p3-p319
Central Precocious Puberty Appeared in Infancy Period in a Patient of Sotos Syndrome
hrp0089p3-p320
Clinical and Endocrinological Manifestations of Partial Ectopic Posterior Pituitary: A New Imaging Entity
hrp0089p3-p418
Sex Differentiation, Gonads and Gynaecology or Sex Endocrinology P1
Insights in Promoter Transactivation of CBX2 Expression
hrp0089p1-p213
In Silico and In vitro Studies of Human SRD5A2 Variants in Search for Activating Variants Explaining Androgen Excess Reveal Additional Loss of Function Variants
hrp0089p1-p214
Mutations Involving Nuclear Receptors and Their Cofactors as a Major Cause of 46,XX DSD
hrp0089p1-p215
SDgeneMatch, A New Tool to Aid the Identification of the Genetic Causes of DSD
hrp0089p1-p216
Reduced Androgen Receptor Expression in Patients with 45,X/46,XY Mosaicism
hrp0089p1-p217
Primary Gonadal Dysgenesis in Male 46,XY Patients with NR5A1 Variants Predominantly Affects Sertoli Cell Function
hrp0089p1-p218
Evaluation of Genetic Etiology in Patients with 46,XY Disorders of Sex Development: One Center Experience
hrp0089p1-p219
Pitfalls in the Diagnosis of An Infant with 46,XX DSD with Congenital Adrenal Hyperplasia due to Cytochrome P450 Oxidoreductase Deficiency - the Value of Simultaneous Genetic Analysis to the Diagnosis in DSD
hrp0089p1-p220
High Mobility Group Box 1 (HMGB1) and Insulin-Like Growth Factor Binding Protein-2 (IGFBP-2) are Increased, Insulin Decreased and IL-6 Unchanged in Follicular Fluid (FF) from Polycystic Ovarian Syndrome (PCOS)
hrp0089p1-p221
A De Novo Missense Mutation in the 4th Zinc Finger of the WT1 Gene Causes 46,XY and 46,XX DSD in Two Sibs
hrp0089p1-p222
Sex-Differences in Reproductive Hormones During Mini-Puberty in Infants with Normal and Disordered Sex Development
hrp0089p1-p223
The 'ExternalGenitaliaScore' to Describe External Genitalia in Male and Female Infants: A Europeanmulticenter Validation Study
hrp0089p1-p224
Living with Clitoromegaly: Aqualitative Interview Study of Parent's Responses to Clitoromegaly in Congenital Adrenal Hyperplasia (CAH) with or Without Appearance Altering Surgery
hrp0089p1-p225
'You Can Put Ideas into Their Heads': Parental Concerns about Children's Participation in DSD Research
hrp0089p1-p226
Testosterone Levels in Newborn Boys and Girls Related to Penile Length, Anogenital Distance (AGD) and External Genitalia Score (EGS)
hrp0089p1-p227
Clinical Factors that Determine Surgical Outcome Following Hypospadias Repair
hrp0089p1-p228
Prevalence of Hypogonadism in Prepubertal Boys with Cryptrochdism
hrp0089p1-p229
Testicular Ultrasound Measurements to Stratify Pituitary-Gonadal Hormone References in a Cross-Sectional Norwegian Study of Male Puberty
hrp0089p1-p230
Altered Vascular Function in Boys with Hypospadias - Role of Reactive Oxygen Species
hrp0089p1-p231
Gonadectomy for Adults with DSD Conditions in the International Disorders of Sex Development Registry
hrp0089p1-p232
Phenotypic and Genetic Assessment of Boys with a Suspected XY Disorder of Sex Development
hrp0089p1-p233
Pediatricians' Attitudes and Beliefs towards Transgender Persons
hrp0089p1-p234
Diagnosis of Adolescent Polycystic Ovary Syndrome (PCOS) According to the 2018 International Evidence-Based Guideline for the Assessment and Management of PCOS
hrp0089p1-p235
Identification and Analysis of the Genetic Causes of Premature Ovarian Failure (POF) in a Cohort of Adolescent Girls
hrp0089p1-p236
Premature Ovarian Insufficiency in Girls Caused by Autosomal Microdeletions: 3 Case Reports
hrp0089p1-p237
Effect of Intrauterine Growth Restriction on Ovarian Follicle Pool
hrp0089p1-p238
Sustainability of Estradiol Drug Concentrations in Cut Matrix Patches; A Study of Different Brands with Potential Use for Pubertal Induction
hrp0089p1-p239
Serum Anti-Mullerian Hormone (AMH) concentrations and Reduced Appendix Testis Estrogen Receptor Expression in Cryptorchidism
hrp0089p1-p240
The Comparisons of the Adult Height Gain and the Menarchal Age of the Girls with Central Precocious Puberty after Gonadotropin Releasing Hormone Agonist Alone and Those Treated with Combined Growth Hormone Therapy
hrp0089p1-p241
AMH Level of Infants with Premature Thelarche and Possible Relationship between AMH and Mini-puberty
hrp0089p1-p242
Circulating Makorin Ring Finger Protein 3 Levels Predict Central Precocious Puberty in Girls
hrp0089p1-p243
Polycystic Ovarian Syndrome in Adolescents: Characterising the Clinical Phenotype and the Role of Precision Medicine
hrp0089p1-p244
Thyroid Function in Central Precocious Puberty Girls
hrp0089p1-p245
Clinical Phenotypes and Mutation Spectrum of Patients with Isolated Gonadotropin-Releasing Hormone Deficiency in a Single Academic Center
hrp0089p1-p246
Evaluation of Hormonal Profiles and Autoantibodies Against Sperm and Leydig Cells in Patients after Testicular Torsion Treatment
hrp0089p1-p247
Sex Differentiation, Gonads and Gynaecology or Sex Endocrinology P2
Physical Assessment in Chinese Children with 5a-reductase Type 2 Deficiency
hrp0089p2-p338
Results of Exome Sequencing in Disorders of Sex Development
hrp0089p2-p339
Awareness is The Key: Heavy Delay in Diagnosis of 17-[beta]-Hydroxysteroid-Dehydrogenase III Deficiency (17bHSD3D) and Other Insights and Conclusions from a Cohort of Ten 17bHSD3D Patients in Germany
hrp0089p2-p340
Evaluation of Three Patients with 46,XY Gonadal Dysgenesis due to Desert Hedgehog Gene Mutations
hrp0089p2-p341
In-silico Gene-protein Analysis and Clinical Phenotype Characterisation of Three Novel NR5A1/SF1 Gene Mutations Presenting with 46,XY DSD
hrp0089p2-p342
Clinical, Biochemical, Structural and Functional Characterization of a Novel P450 Oxidoreductase Mutation Causing Virilization in a 46,XX Patient
hrp0089p2-p343
Copy-Number Variations of the Human Olfactory Receptor Gene Family in Patients with Macromastia and Prepubertal Gynecomastia
hrp0089p2-p344
Histopathologic Characterization of Patients with 46,XX Testicular and Ovotesticular Disorders of Sex Development
hrp0089p2-p345
Current Medical Care of Children and Adolescents with Disorders/differences of Sex Development in Switzerland
hrp0089p2-p346
Clinical, Laboratory and Molecular Genetic Findings of Patients with 17[beta]-Hydroxysteroid Dehydrogenase 3 Deficiency
hrp0089p2-p347
Revisiting the Diagnosis: Next Generation Sequencing (NGS) Identifies Concurrence of PAIS in a Previously Reported Case of Klinefelter Syndrome (47,XXY) with Hypospadias
hrp0089p2-p348
A 46,XX Female with WT1 Mutation, Congenital Nephrotic Syndrome and a Complex Disorder of Sex Development
hrp0089p2-p349
Psychological Gender Features and Social Abilities and in Adolescent Girls - Influence of Obesity and Hyperandrogenism
hrp0089p2-p350
Two Unrelated Cases of Severe Insulin Resistance Due to Insulin Receptor Mutation Discovered During Adolescence
hrp0089p2-p351
A Systematic Review of Reported Outcomes for Hypospadias
hrp0089p2-p352
Young Transgender People's Attitudes to Fertility Preservation and Practice
hrp0089p2-p353
Etiology of Disorders of Sex Development in Kenyan Children and Adolescents
hrp0089p2-p354
Adiponectin as a Marker of Peripheral Insulin Resistance in Adolescents with Polycystic Ovarian Syndrome (PCOS) and as a Tool to Suspect Insulin Receptor Defects
hrp0089p2-p355
Diagnostic Experiences and Concerns in Adolescents with Polycystic Ovary Syndrome
hrp0089p2-p356
Impact of Hydrocortisone Treatment on Clitoral Size During First Year of Life in Girls with Congenital Adrenal Hyperplasia (CAH)
hrp0089p2-p357
Persistent Mullerian Duct Syndrome: Rare But Important Aetiology of an Inguinal Hernia and Cryptorchidism in Boys
hrp0089p2-p358
Clinical, Hormonal and Metabolic Profile in Adolescent Girls Treated with Gonadotropin Releasing Hormone Agonist for Idiopathic Central Precocious Puberty
hrp0089p2-p359
Spontaneous Pregnancies in Female Survivors of Childhood Hematological Malignancies Post Allogeneic Haemopoietic Stem Cell Transplantation
hrp0089p2-p360
Towards an Integrated Approach to Diagnosis of 46,XY Disorder of Sex Development
hrp0089p2-p361
Mini-Puberty in Boys with Inguinal Cryptorchidism
hrp0089p2-p362
The Human Genital Tubercle is Steroidogenic Organ at Earlypregnancy
hrp0089p2-p363
Transgender Medicine is a Significant Part of Paediatric Endocrinology
hrp0089p2-p364
Prospective Investigation of the Influence of Triptorelin Treatment on Body Weight and Body Mass Index of Girls Who Were Diagnosed with Idiopathic Precocious Puberty or Early Puberty
hrp0089p2-p365
Genetic Etiologies and Gender Outcomes of Patients with Disorders of Sex Development Presenting with Asymmetric Gonads
hrp0089p2-p366
A Rare Form of Ovotesticular DSD: Diagnostic and Management Challenges
hrp0089p2-p367
A Case of Gonadal Dysgenesis Due to a Novel Homozygous Mutation in NR5A2 Gene
hrp0089p2-p368
Assessment of Initial Investigation Requested in Adolescents with Menstrual Disorders
hrp0089p2-p369
Persistent Mullerian Duct Syndrome in Twin Brothers Caused by a Novel Mutation in the AMHR2 Gene
hrp0089p2-p370
No Difference in Cognitive Performance or Gender Role Behaviour in Men with and without Hypospadias
hrp0089p2-p371
Assessment of the Gonadotrophin-Gonadal Axis and Sertoli Cell Function in Partial Androgen Insensitivity Syndrome
hrp0089p2-p372
Prevalence and Ethiologic Factors of Hirsutism in Adolescents
hrp0089p2-p373
Evaluation of Serum Anti-Mullerian Hormone and Androstenedione Levels in Adolescents Girls with Menstrual Irregularities
hrp0089p2-p374
Could Basal AMH Replace hCG Stimulation Test in XY Disorder of Sex Development Cases
hrp0089p2-p375
Sex Differentiation, Gonads and Gynaecology or Sex Endocrinology P3
Gonadal Tumor Incidence in Patients with Disorders of Sex Development Containing Y Chromosome or Y-derived Sequences - Experience from One Clinical Center
hrp0089p3-p321
New Method of Surgical Correction of Female Hypospadias in Girls with Disorders of Sex Development and Stenosis of Artificial Introitus
hrp0089p3-p322
Novel Mutation in Two Related 46, XY Phenotypic Females with 17[beta]-Hydroxysteroid Dehydrogenase 3 Deficiency
hrp0089p3-p323
Challenges in Managing 46, XY Partial Gonadal Dysgenesis in Saudi Arabia
hrp0089p3-p324
A Paternally Inherited NR5A1 Mutation in a Case of 46,XY Partial Gonadal Dysgenesis
hrp0089p3-p325
Clinical Presentation and Characteristics of DSD in Kenyan Children and Adolescents
hrp0089p3-p326
Evolutive Profile of Pauci-symptomatic Forms of Mc Cune Albright Syndrome
hrp0089p3-p327
A 45X0/46XY Girl Diagnosed with Prepubertal FSH Elevation
hrp0089p3-p328
About a Case of Leydig Cell Tumor Associated with Central Precocious Puberty
hrp0089p3-p329
Gender Dysphoria
hrp0089p3-p330
GnRH Analogues and Cross-Sex Hormonal therapy: Side Effects in Transgender Youth
hrp0089p3-p331
Klinefelter Syndrome with Low Gonadotropin Levels
hrp0089p3-p332
Young Male Adolescent with Gender Dysphoria (GD)/Gender Incongruence - A Case Presentation
hrp0089p3-p333
Effect of Gonadotropin-Releasing Hormone Agonist Treatment in Boys with Central Precocious Puberty and Early Puberty
hrp0089p3-p334
DSD in Ukraine: Our Experience
hrp0089p3-p335
A Turkish Family with 46,XY Disorder of Sex Development Due to 17b-Hydroxysteroid Dehydrogenase Type 3 Deficiency
hrp0089p3-p336
Normal External Genitalia in a Female with Classic, Salt-Wasting 21-Hydroxylase Deficiency
hrp0089p3-p337
Ovarian Leydig Cell Tumor in an 8 Years Old Girl Misdiagnosed as Congenital Adrenal Hyperplasia Due to Elevated 17-Hydroxi-Progesterone
hrp0089p3-p338
Analysis of Genetic Mutations in a Chinese Pedigree Affected with Idiopathic Hypogonadotropic Hypogonadism Syndrome
hrp0089p3-p339
Cytogenetic Spectrum of Ovotesticular Disorder of Sex Development in Egyptian DSD Patients
hrp0089p3-p340
Cytogenetic Spectrum of Ovotesticular Disorder of Sex Development in Egyptian DSD Patients
hrp0089p3-p341
Characterization of Genotype-Phenotype in Inter-Familial and Intra-Familial Patients with Same Mutation of SRD5A2 Gene
hrp0089p3-p342
Genital Abnormalities and Management Outcomes as Seen in the University of Port Harcourt Teaching Hospital
hrp0089p3-p343
A Case Report: A Girl with 46,XY Karyotype and Disorder of Androgen Synthesis
hrp0089p3-p344
The Positive Effect of the Low-Dose Contraceptive on the Course of Cystic Fibrosis in the Adolescent Female
hrp0089p3-p345
Ovotesticular Disorder of Sexual Development: 31 Cases Followed-up in a Single-Center in Brazil
hrp0089p3-p346
Genital Swelling and Ovarian Stimulation Syndrome in an Extremely Preterm Infant
hrp0089p3-p347
Significant Penile Growth with Local DHT-Gel in an Infant with 17-Beta HSD-Deficiency
hrp0089p3-p348
Mother and Baby Diagnosed Noonan Syndrome with Dysmorphic Findings
hrp0089p3-p349
5-Alpha Reductase Type 2 Deficiency among Iranian Patients with Ambiguous Genitalia
hrp0089p3-p350
A Case Report of Spironolactone Treatment for Becker's Nevus Associated Ipsilateral Breast Hypoplasia
hrp0089p3-p351
New Mutation in 5-Alpha-Redoctase: A Five-Month-Old Infant with a Karyotype of 46 XY
hrp0089p3-p352
A Novel Compound Heterozygous Mutation in CYP19A1 Resulting in Aromatase Deficiency with Normal Gonadotropin Levels and Ovarian Tissue
hrp0089p3-p353
Emblematic Case CAH
hrp0089p3-p354
The Republic of Colombia Has a Constitutional Jurisprudential Precedent Identified as T622 of 2014,1 This Sentence Reaffirms the Importance of the Accurate Diagnosis of Intersexual Patients and Updates How the State Looks at Them2
hrp0089p3-p355
Paediatric Doctors' Experience and Knowledge of the Initial Management of Neonatal Ambiguous Genitalia
hrp0089p3-p356
A Case of Transverse Testicular Ectopia with Persistant Mullerian Duct Syndrome: A Novel AMH Gene Mutation
hrp0089p3-p357
Argentinean First Experience with Transgender Children and Youths
hrp0089p3-p358
Long-Term Follow-up in a Chinese Child with Lipoid Congenital Adrenal Hyperplasiadue to STARmutation
hrp0089p3-p359
46,XY Gonadal Dysgenesis Accompanied by Neuropathy Caused by a DHH Mutation
hrp0089p3-p360
Clinical and Molecular Characterization of One Nr5a1 Gene Mutation Found in a Patient WITH 46, XY DSD
hrp0089p3-p400
Genetic Testing by SNP Array Analysis in A Group of Romanian Patients with Disorders of Sexual Development
hrp0089p3-p408
A Novel Gene Mutation and Atypical Clinical Phenotype of Kallmann Syndrome
hrp0089p3-p409
Thyroid P1
Early Determinants of Thyroid Function Outcome in Children with Congenital Hypothyroidism and a Normally Located Thyroid Gland: A Regional Cohort Study
hrp0089p1-p248
Neonatal Screening for Congenital Hypothyroidism: Age-dependent Reference Intervals for Dried Blood Spot TSH in the Neonatal Period
hrp0089p1-p249
Thyroid Scintigraphy in the Diagnosis of Congenital Hypothyroidism
hrp0089p1-p250
Congenital Hypothyroidism (CH) with Delayed TSH Elevation: The Importance of The Second-Screening Strategy and the Evolution of CH in Preterm Infants
hrp0089p1-p251
Morning Versus Bedtime Levothyroxine Administration: What is the Choice of Children?
hrp0089p1-p252
Long Term Comparison between Liquid and Tablet Formulations of L-Thyroxine (L-T4) in the Treatment of Congenital Hypothyroidism (CH)
hrp0089p1-p253
Isolated Congenital Central Hypothyroidism due to a Novel Mutation in TSH Beta Subunit Gene
hrp0089p1-p254
Patterns of Thyroglobulin Levels in Infants Referred With High TSH on Newborn Screening, Compared with Iodine-sufficient Healthy Controls
hrp0089p1-p255
Mutation Screening in 60 Chinese Patients with Congenital Hypothyroidism
hrp0089p1-p256
Results of the hTPO Mutational Screening in Bulgarian Patients with Congenital Hypothyroidism (CH)
hrp0089p1-p257
Thyroid Hormone Resistance Beta: Eighteen Pediatric Patient Experience
hrp0089p1-p258
A Novel Mutation of IGSF1 Gene
hrp0089p1-p259
Multinodular Goiter in Childhood: A Diagnostic Gateway for Screening DICER1 Syndrome
hrp0089p1-p260
A Novel DICER1 Mutation Identified in a Family with the Multinodular Goiter of Children
hrp0089p1-p261
Subclinical Hypothyroidism, Thyroid Nodule or Cyst in Prepubertal Children: How Many Children were Diagnosed at Age 6?
hrp0089p1-p262
Expression of ZnT8 Transporter in Thyroid Tissues from Patients with Immune and Non-Immune Thyroid Diseases
hrp0089p1-p263
Thyroid Nodules in a Childhood Cancers Survivors Population: A Monocentric Experience
hrp0089p1-p264
HLA Alleles and Amino Acid Variants of HLA-A, -B, -C, -DRB1, -DQB1, -DPB1 Molecules in Early-Onset Autoimmune Thyroid Disease
hrp0089p1-p265
Childhood Thyroid Autoimmunity and Relation to Islet Autoantibodies in Children at Risk for Type 1 Diabetes
hrp0089p1-p266
Evaluation of Serum Concentrations of Selected Cytokines OPG and sRANKL in the Diagnosis of Autoimmune Thyroid Disease in Children
hrp0089p1-p267
Analysis of Zinc-Transporter ZnT8 Autoantibodies in Children and Adolescents with Autoimmune Thyroid Diseases
hrp0089p1-p268
The Association between TSHR, IFIH1 and ETV5 Polymorphisms with Graves' Disease and Diabetes Mellitus Type 1 in Children
hrp0089p1-p269
Thyroid P2
Long Term Monitoring of Graves Disease in Children and Adolescents: Single Center Experience
hrp0089p2-p376
Effects of Thyroid Autoimmunity on Non-Alcoholic Fatty Liver Disease in Euthyroid Girls with Hashimoto's Thyroiditis
hrp0089p2-p377
The Prevalence of Clinically Significant Anti-TPO Positivity in Children with HLA-Conferred Susceptibility to Type 1 Diabetes
hrp0089p2-p378
Encephalopathy Associated with Autoimmune Thyroid Disease: A Case Report
hrp0089p2-p379
Celiac Disease Screening Should be Routinely Offered in Pediatric Population with Autoimmune Thyroid Disease
hrp0089p2-p380
Autoimmune Thyroiditis in Klippel-Feil Syndrome with Arnold Chiari and Syringomyelia
hrp0089p2-p381
Neonatal Monitoring of Newborns Born from Mothers with Graves' Disease: Results of a Retrospective Monocentric Study
hrp0089p2-p382
A Successful Switch Experience from High-dose PTU to MMI on Day 4 of Graves' Thyroid Storm in a 14-Year-Old Girl
hrp0089p2-p383
Graves's Disease During Pregnancy: The Impact on the Fetus and the Newborn
hrp0089p2-p384
Thyroid Hormone Receptor [beta] (THRB) Mutation: Two New Cases of Heterozygous Mutation with Significant Family History
hrp0089p2-p385
Triac Treatment Response to Thyroid Hormone Resistantance
hrp0089p2-p386
Phenotype and Genotype of Four Patients with Thyroid Hormone Resistance Syndrome due to Mutations in the THRB Gene
hrp0089p2-p387
Clinical Course in a Girl with Two hTPO Mutations - Homozygous c.1268G>A (p.Gly393Arg) and Heterozygous c.208C>G (p.Ala70Pro): 27 Years of Follow Up
hrp0089p2-p388
A Neurological Disease Mimicking Central Hypothyroidism: MCT8 Deficiency
hrp0089p2-p389
Multinodular Goiter in Childhood: Look for DICER1 Mutation
hrp0089p2-p390
Application of Elastography in Assesment of Different Benign Thyroid Lesions in Children and Adolescents
hrp0089p2-p391
Clinical Characteristics and Predictive Factors for the Detection of Thyroid Cancer in Children with Thyroid Nodules
hrp0089p2-p392
Thyroid Nodules in Prader-Willi Syndrome
hrp0089p2-p393
Early Medullary Thyroid Carcinoma (MTC) in an Infant with Multiple Endocrine Neoplasia Type 2B (MEN2B, RETS Mutation codon 891)
hrp0089p2-p394
Serum Level of Biotin Rather than the Daily Dose is the Main Determinant of the Interference on Thyroid Function Assays in Patients with Biotinidase Deficiency
hrp0089p2-p395
Thyroid Function Tests and Affecting Factors in Twins and Triplets
hrp0089p2-p396
Hypothyroidism in a Child During Treatment with Nivolumab for a Glioblastoma
hrp0089p2-p397
Diagnosis and Clinical Course of Amiodarone Induced Hyperthyroidism in Three Adolescent Patients
hrp0089p2-p398
Allogenic Bone Marrow Transplantation in Children: Effect on Thyroid Function
hrp0089p2-p399
Follow-up in Children with Non-obese and Non-autoimmune Subclinical Hypothyroidism
hrp0089p2-p400
Clinical Management of Childhood Hyperthyroidism: A Longitudinal Study at a Single Center
hrp0089p2-p401
Association of Thyroid Stimulating Hormone and Free Thyroxine with Cardiometabolic Risk Factors in Euthyroid Korean children and Adolescents Aged 10-18 Years: The Korean National Health and Nutrition Examination Survey 2015
hrp0089p2-p402
Asymptomatic Hyperthyrotropinaemia in Children, Does it Correlate to true Thyroid Gland Dysfunction?
hrp0089p2-p403
Hearing Loss Among Patients with Congenital Hypothyroidism
hrp0089p2-p404
Predictors of Permanent Congenital Hypothyroidism in Children
hrp0089p2-p405
Absence of Uptake on Scintigraphy Does Not Always Correlate with Athyreosis: Re-evaluation of Patients Diagnosed with Athyreosis Over a 10 Year Period in the Republic of Ireland
hrp0089p2-p406
Bannayan-Riley-Ruvalcaba Syndrome with PTEN Mutation in a Patient Affected by Congenital Hypothyroidism due to TPO Gene Alteration
hrp0089p2-p407
The Congenital Hypothyroidism Screening Programme in a Sigle Italian Centre: a 5-Years Retrospective Study
hrp0089p2-p408
Do Insulin Like Growth Factors also Influence Growth in Children with Congenital Hypothyroidism: A Cohort Analysis
hrp0089p2-p409
Study of Hearing Function in Children with Congenital Hypothyroidism Attending Alexandria University Children's Hospital
hrp0089p2-p410
Awareness of the Risks of Acquired Iodine Deficiency in Strict Vegan Diets
hrp0089p2-p411
Thyroid Function in the Korean Obese Children and Adolescents: Korea National Health and Nutrition Examination Survey 2013 to 2015
hrp0089p2-p412
Thyroid P3
Prevalence and Demographic Profile of Thyroid Disorders in Indian Children
hrp0089p3-p361
Graves' Disease in a Pediatric Population: Results from the Last 17 Years at a Pediatric Endocrinology Unit
hrp0089p3-p362
Acquired Severe Hypothyroidism in Children - Forgotten or Unbelievable Diagnosis in a Time of Large and Easy Availability of Thyroid Tests?
hrp0089p3-p363
Thyroid Disorders and Autoimmunity in Children and Adolescents with Type 1 (T1DM) and Type 2 Diabetes Mellitus (T2DM)
hrp0089p3-p364
The Reference and Follow-up Signs and Symptoms of the Cases Who Are Diagnosed As Hyperthyroidism
hrp0089p3-p365
Clinical Features in Childhood Graves' Disease
hrp0089p3-p366
General Characteristics of Autoimmune Thyroid Diseases and Evaluation of Accompanied Morbiditis
hrp0089p3-p367
Amiodarone Induced Hyperthyroidism in a Pediatric Patient
hrp0089p3-p368
Abstract unavailable
hrp0089p3-p369
Thyroid Carcinoma in Children: 7 Years' Experience of a Single Center
hrp0089p3-p370
Autoimmune Thyroiditis (Hashimoto Thyroiditis) in a Known Case of Autoimmune Hemolytic Anemia
hrp0089p3-p371
Dento - Maxillary and Periodontal Changes in Puberty/Adolescence in Subclinical Hypothyroidism of Autoimmune Cause
hrp0089p3-p372
Hypovitaminosis D and Chronic Autoimmune Thyroiditis Mammary Echostructural Involvements in Puberty
hrp0089p3-p373
Two Contrasting Cases of Solitary Thyroid Nodules in Adolescent Girls
hrp0089p3-p374
Congenital Hypothyroidism - Diagnose Early and Keep Going
hrp0089p3-p375
An Impressive Recovery of Arrested Growth and Puberty in a 13 Year Old Boy after Being Treated for Simultaneously Diagnosed Severe Hypothyroidism and Coeliac Disease
hrp0089p3-p376
A Very Rare Thyroid Hormone Resistance Case Having Heterozygous Mutation in THRB Genes
hrp0089p3-p377
Clinical Case (Children's Endocrinology)
hrp0089p3-p378
Thyroid Imaging Study for the Diagnosis of Congenital Hypothyroidism with Thyroid Dysgenesis
hrp0089p3-p379
A Case of Permanent Congenital Hypothyroidism with Compound Heterozygous Mutations in the DUOX2 Gene
hrp0089p3-p380
Growth Catch-up on Acquired Hypothyroidism Presenting with Growth Delay
hrp0089p3-p381
Thyroid Disease in Children and Adolescences with Down Syndrome- 16 Years of Follow Up in a Single Service
hrp0089p3-p382
Corticosteroid Resistant Immune Thrombocytopenic Purpura, is it a Marker of Future Graves Disease?
hrp0089p3-p383
Neonatal Hypothyroidism following Transplacental Amiodarone Treatment for Supraventricular Tachyarrhythmia
hrp0089p3-p384
Rare Case Report of Thyroiditis De Quervain in a Six Years Old Girl
hrp0089p3-p385
Papillary Thyroid Carcinoma in a 7 Year Old Boy Presenting with a Goiter Without Microcalcifications and Enlarged Cervical Lymph Nodes
hrp0089p3-p386
Graves' Disease, Methimazole and SLE-like Reaction:A Case Report
hrp0089p3-p387
A Rare Case of Pediatric Hyperthyroidism
hrp0089p3-p388
Allan-Herndon-Dudley Syndrome in a Patient with Global Delay Development - a Case Report
hrp0089p3-p389
Multi Autoimmune Phenomenon in Indian Children with Thyroid Disorder
hrp0089p3-p390
Levothyroxine Treatment of Subclinical (SH) and Overt (OH) Hypothyroidism in Children with Autoimmune Hashimoto Thyroiditis (AHT): A Retrospective Study in Regard with TSH and Free T4 (FT4) at Diagnosis
hrp0089p3-p391
Hashitoxicosis:a Rare Diagnosis in Childhood
hrp0089p3-p392
An Assay Led Astray: A Curious Case of Biotin-Induced Hyperthyroidism
hrp0089p3-p393
A Case of Steroid-Responsive Encephalopathy Associated with Autoimmune Thyroiditis (SREAT) in a Girl with Newly Diagnosed Hashimoto Thyroiditis
hrp0089p3-p394
Intellectual Outcome at Childhood in Congenital Hypothyroidism According to Etiology and Treatment Related Factors
hrp0089p3-p395
Myastenia Gravis in a Girl with Hashimoto Thyroiditis
hrp0089p3-p396
Head Circumference, Birth Length, and Weight of Neonates of Mothers with Hypothyroidism
hrp0089p3-p397
Late Breaking P1
A Second Growth Hormone Receptor Pseudoexon Mutation Causing Frameshift and Severe Postnatal Growth Failure
hrp0089lb-p1
Abstract unavailable
hrp0089lb-p2
Glycemic Impact of Long Term Use of Diazoxide Choline Controlled-Release Tablets in Patients with Prader-Willi Syndrome or with Very High Triglycerides
hrp0089lb-p3
An Updated Evolutionary Study in Glucocorticoid Receptors; Insights from a Comprehensive Phylogenetic, SNP's and Mutation's Analysis of the Nuclear Receptors Family: An Updated Evolutionary Study in Glucocorticoid Receptors; Insights from a Comprehensive Phylogenetic, SNP's and Mutation's Analysis of the Nuclear Receptors Family
hrp0089lb-p4
Association between the Use of Antenatal Steroids for Lung Maturation and Hypoglycemia in Newborns Between 26 and 34 6/7 Weeks of Gestation
hrp0089lb-p5
Sex Hormone Levels in Young Children: a Pilot Study of the Japan Environment and Children's Study
hrp0089lb-p6
Mutational Analysis of SRD5A2 and AR Genes in Indian Children with 46 XY Disorders of Sex Development
hrp0089lb-p7
Pharmacokinetics of Diazoxide Choline Controlled-Release Tablets, a Once Daily Treatment Being Evaluation in Patients with Prader Willi Syndrome
hrp0089lb-p8
Two Siblings with Autosomal Recessive Syndromic Hypopituitarism Caused By Mutations in TBC1D32
hrp0089lb-p9
The Influence of Oil-Soluble Iodinated Contrast Medium (Lipiodol) on Child's Thyroid Function in Mice
hrp0089lb-p10
Metabolic Profile in Survivors of Pediatric Hematopoietic Stem Cells Transplantation after Chemotherapy-Only Conditioning
hrp0089lb-p11
Disrupting the Norm: The Experience of Young People with DSD
hrp0089lb-p12
Clinical and Endocrine Characteristics and Genetic Analysis of Korean Children with McCune-Albright Syndrome
hrp0089lb-p13
Beta-cell Function in Chinese Youngsters with Type 1 Diabetes and Assessment of Surrogate Markers of Severe Insulin Deficiency
hrp0089lb-p14
A Novel Compound Heterozygous Mutation of the CYP17A1 Gene is Associated with Rhabdomyolysis: Demonstration of Combining 17[alpha]-hydroxylase/17,20-Lyase Deficiency
hrp0089lb-p15
Successful Treatment of Alopecia Totalis with Calcitriol and Paricalcitol in Two Girls Aged 3 and 7-Years
hrp0089lb-p16
Protein-Induced Hypoglycemia Secondary to Hyperinsulinism-Hyperammonemia (HI/HA) Syndrome: A GLUD1 Gene Mutation
hrp0089lb-p17
The Efficacy of GnRHa alone or in Combination with rhGH for the Treatment of Idiopathic Central Precocious Puberty or Early and Fast Puberty in Chinese Girls
hrp0089lb-p18
Characterization and Clinical Course of Prolactinoma in Korean Adolescents
hrp0089lb-p19
The Efficacy and Safety of Octreotide Treatment for Diazoxide-Unresponsive Congenital Hyperinsulinism in China
hrp0089lb-p20